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Abstract
Pollution studies have sought to understand the relationships between adverse
health effects and harmful exposures. Many environmental health studies are
predicated on the idea that each exposure has both acute and long term health ef-
fects that need to be accurately mapped. Considerable work has been done linking
air pollution to deleterious health outcomes but the underlying biological path-
ways and contributing sources remain difﬁcult to identify. There are many statis-
tical issues that arise in the exploration of these longitudinal study designs such
as understanding pathways of effects, addressing missing data, and assessing the
health effects of multipollutant mixtures. To this end this dissertation aims to ad-
dress the afore mentioned statistical issues.
Our ﬁrst contribution investigates the mechanistic pathways between air pollu-
tants and measures of cardiac electrical instability. The methods from chapter 1
propose a path analysis that would allow for the estimation of health effects ac-
cording to multiple paths using structural equation models. Our second contri-
bution recognizes that panel studies suffer from attrition over time and the loss of
data can affect the analysis. Methods from Chapter 2 extend current regression cal-
ibration approaches by imputing missing data through the use of moving averages
and assumed correlation structures. Our last contribution explores the use of fac-
tor analysis and two-stage hierarchical regression which are two commonly used
approaches in the analysis of multipollutant mixtures. The methods from Chap-
iiiter 3 attempt to compare the performance of these two existing methodologies for
estimating health effects from multipollutant sources.
ivContents
Title page . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . i
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xv
1 Distributed Lag Path Analysis: Cardiovascular Effects of Ambient Air
Pollution 1
1.1 ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.3 DATA DESIGN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3.1 Data Collection . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.3.2 Single Outcome Analyses . . . . . . . . . . . . . . . . . . . . . 7
1.4 MODEL AND NOTATION . . . . . . . . . . . . . . . . . . . . . . . . 9
1.4.1 Modeling Framework . . . . . . . . . . . . . . . . . . . . . . . 9
1.4.2 Distributional Assumptions . . . . . . . . . . . . . . . . . . . . 11
1.4.3 The Pathway Analytic Model . . . . . . . . . . . . . . . . . . . 12
1.5 DIRECT AND INDIRECT EFFECTS . . . . . . . . . . . . . . . . . . . 16
1.5.1 Interpretation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.6 ESTIMATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.7 SIMULATION STUDY . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
v1.7.1 Simulating Lagged Data . . . . . . . . . . . . . . . . . . . . . . 19
1.7.2 Simulating Outcome 1 . . . . . . . . . . . . . . . . . . . . . . . 19
1.7.3 Simulating Outcome 2 . . . . . . . . . . . . . . . . . . . . . . . 20
1.7.4 Simulation Path Model . . . . . . . . . . . . . . . . . . . . . . . 20
1.7.5 Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.8 DATA ANALYSIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.8.1 Prior Elicitation . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.8.2 Health effects analysis . . . . . . . . . . . . . . . . . . . . . . . 26
1.8.3 Path Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
1.9 DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.10 APPENDIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
1.10.1 Proof Direct and Indirect Effects . . . . . . . . . . . . . . . . . 35
1.10.2 Simulations Scenarios 1-7 . . . . . . . . . . . . . . . . . . . . . 39
2 New regression Calibration Approaches for Missing Exposure Data in
Panel Studies 45
2.1 ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
2.2 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.3 DATA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
2.4 MOVING AVERAGE IMPUTATION . . . . . . . . . . . . . . . . . . . 51
2.4.1 Simple Exposure Model Including of Covariates . . . . . . . . 52
2.4.2 Distribution of the Moving Average . . . . . . . . . . . . . . . 54
2.4.3 Nonparametric Moving Average Imputation . . . . . . . . . . 60
2.4.4 Data Reduction and Daily Imputation . . . . . . . . . . . . . . 62
2.4.5 Regression Calibration . . . . . . . . . . . . . . . . . . . . . . . 63
2.5 SIMULATION STUDY . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
2.5.1 Simulating The Moving Average Data . . . . . . . . . . . . . . 65
2.5.2 Simulating Outcome . . . . . . . . . . . . . . . . . . . . . . . . 66
2.5.3 Relaxing the AR(1) Assumption . . . . . . . . . . . . . . . . . 68
vi2.5.4 Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . 73
2.6 DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
2.7 APPENDIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
3 Health Effects of Multipollutant Mixtures: Testing Properties of Source
Apportionment and Two-Stage Hierarchical Regression Methods 81
3.1 ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
3.2 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
3.3 DATA AND STUDY DESIGN . . . . . . . . . . . . . . . . . . . . . . . 86
3.4 MODEL AND NOTATION . . . . . . . . . . . . . . . . . . . . . . . . 87
3.4.1 Factor Analysis Modeling Framework . . . . . . . . . . . . . . 87
3.4.2 Two-Stage Hierarchical Regression Modeling Framework . . 89
3.5 SIMULATION STDY . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
3.5.1 Simulating Source Data . . . . . . . . . . . . . . . . . . . . . . 97
3.5.2 Simulating Health Outcome Data . . . . . . . . . . . . . . . . 100
3.5.3 Approaches . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
3.5.4 Choice of Second Stage Covariates . . . . . . . . . . . . . . . . 102
3.5.5 Simulation Results . . . . . . . . . . . . . . . . . . . . . . . . . 104
3.5.6 Simulation Implications . . . . . . . . . . . . . . . . . . . . . . 108
3.6 DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
3.7 APPENDIX . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
4 References 129
viiList of Figures
1.1 General Form . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.2 DAG for Air pollutant exposure . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.3 Model 1-Regular HRV; Regular TWA . . . . . . . . . . . . . . . . . . . . . . 24
1.4 Top Row: SINGLE OUTCOME MODEL HRV - Each graph represents the DL
function of the relationship between PM2:5 and HRV adjusting for subject, day of
week, average heart rate, mean temperature, hour of the day, and date. Bottom
Row: SINGLE OUTCOME MODEL TWA - Each graph represents the DL function
of the relationship between PM2:5 and TWA adjusting for subject, day of week,
average heart rate, mean temperature, hour of the day, and date. . . . . . . . . . 27
1.5 QUADRATIC PATH MODEL - Clockwise : 1) PM2:5 on HRV, 2) PM2:5 on TWA,
3) PM2:5 on TWA indirectly through HRV, and 4) HRV on TWA. . . . . . . . . . 29
1.6 CUBICPATHMODEL-Clockwise: 1)PM2:5 onHRV,2)PM2:5 onTWA,3)PM2:5
on TWA indirectly through HRV, and 4) HRV on TWA. . . . . . . . . . . . . . . 30
1.7 QUARTIC PATH MODEL - Clockwise : 1) PM2:5 on HRV, 2) PM2:5 on TWA, 3)
PM2:5 on TWA indirectly through HRV, and 4) HRV on TWA. . . . . . . . . . . 31
1.8 Model 2-No Effect HRV; Regular TWA . . . . . . . . . . . . . . . . . . . . . . 39
1.9 Model 3-Shifted Effect HRV; Regular TWA . . . . . . . . . . . . . . . . . . . . 40
1.10 Model 4-Regular HRV; Shifted Effect TWA . . . . . . . . . . . . . . . . . . . . 41
1.11 Model 5-Heavy end Effect HRV; Regular TWA . . . . . . . . . . . . . . . . . . 42
1.12 Model 6-Positive Effect HRV; Regular TWA . . . . . . . . . . . . . . . . . . . 43
1.13 Model 7-Positive Effect HRV (downward); Regular TWA . . . . . . . . . . . . . 44
3.1 Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	given : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top
right): The type 1 error for ^ 2 of each health effects model at a given initial value
of 1. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 1. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 1. . . . . . . . . . . . . . . . . . . . 104
viii3.2 Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2.
B(top right): The power for ^ 2 of each health effects model at a given initial value
of 2. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 2. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 2. . . . . . . . . . . . . . . . . . . . 105
3.3 CFA Bootstrap Power and Type 1 Error Curves for Y1tjS1t and 	given : A(top
left): The power for each health effects model at the given initial value of 11.
B(top right): The type 1 error for each of the health effects models at a given
initial value of 12. C(bottom left): The type 1 error for each of the health effects
models at a given initial value of 13. D(bottom right): The type 1 error for each
of the health effects models at a given initial value of 14. . . . . . . . . . . . . 113
3.4 CFA Overlaid Power and Type 1 Error Curves for Y2tjS2t and 	given : A(top left):
The type 1 error for each of the health effects models at a given initial value of 21.
B(top right): The power for each health effects model at the given initial value of
22. C(bottom left): The type 1 error for each of the health effects models at a
given initial value of 23. D(bottom right): The type 1 error for each of the health
effects models at a given initial value of 24. . . . . . . . . . . . . . . . . . . 114
3.5 CFA Bootstrap Power and Type 1 Error Curves for Y1tjS1t and 	given : A(top
left): The power for each health effects model at the given initial value of 11.
B(top right): The type 1 error for each of the health effects models at a given
initial value of 12. C(bottom left): The type 1 error for each of the health effects
models at a given initial value of 13. D(bottom right): The type 1 error for each
of the health effects models at a given initial value of 14. . . . . . . . . . . . . 115
3.6 CFA Overlaid Power and Type 1 Error Curves for Y2tjS2t and 	given : A(top left):
The type 1 error for each of the health effects models at a given initial value of 21.
B(top right): The power for each health effects model at the given initial value of
22. C(bottom left): The type 1 error for each of the health effects models at a
given initial value of 23. D(bottom right): The type 1 error for each of the health
effects models at a given initial value of 24. . . . . . . . . . . . . . . . . . . 116
3.7 Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	given : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top
right): The type 1 error for ^ 2 of each health effects model at a given initial value
of 1. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 1. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 1. . . . . . . . . . . . . . . . . . . . 117
3.8 Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2.
B(top right): The power for ^ 2 of each health effects model at a given initial value
of 2. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 2. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 2. . . . . . . . . . . . . . . . . . . . 118
ix3.9 Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 3.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 3. C(bottom left): The power for ^ 3 of each health effects model at a
given initial value of 3. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 3. . . . . . . . . . . . . . . . . . . . 119
3.10 Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 4.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 4. C(bottom left): The type 1 error for ^ 3 of each health effects model
at a given initial value of 4. D(bottom right): The power for ^ 4 of each health
effects model at a given initial value of 4. . . . . . . . . . . . . . . . . . . . 120
3.11 Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	13 : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top
right): The type 1 error for ^ 2 of each health effects model at a given initial value
of 1. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 1. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 1. . . . . . . . . . . . . . . . . . . . 121
3.12 Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	13 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2.
B(top right): The power for ^ 2 of each health effects model at a given initial value
of 2. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 2. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 2. . . . . . . . . . . . . . . . . . . . 122
3.13 Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	13 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 3.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 3. C(bottom left): The power for ^ 3 of each health effects model at a
given initial value of 3. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 3. . . . . . . . . . . . . . . . . . . . 123
3.14 Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	13 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 4.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 4. C(bottom left): The type 1 error for ^ 3 of each health effects model
at a given initial value of 4. D(bottom right): The power for ^ 4 of each health
effects model at a given initial value of 4. . . . . . . . . . . . . . . . . . . . 124
3.15 Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	31 : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top
right): The type 1 error for ^ 2 of each health effects model at a given initial value
of 1. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 1. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 1. . . . . . . . . . . . . . . . . . . . 125
x3.16 Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	31 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2.
B(top right): The power for ^ 2 of each health effects model at a given initial value
of 2. C(bottom left): The type 1 error for ^ 3 of each health effects model at a
given initial value of 2. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 2. . . . . . . . . . . . . . . . . . . . 126
3.17 Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	31 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 3.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 3. C(bottom left): The power for ^ 3 of each health effects model at a
given initial value of 3. D(bottom right): The type 1 error for ^ 4 of each health
effects model at a given initial value of 3. . . . . . . . . . . . . . . . . . . . 127
3.18 Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	31 : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 4.
B(top right): The type 1 error for ^ 2 of each health effects model at a given initial
value of 4. C(bottom left): The type 1 error for ^ 3 of each health effects model
at a given initial value of 4. D(bottom right): The power for ^ 4 of each health
effects model at a given initial value of 4. . . . . . . . . . . . . . . . . . . . 128
xiList of Tables
1.1 This table represents the initial values chosen for the simulation study. For each
model, 4 initial values were chosen for both HRV and TWA. Each model corre-
sponds to a distinct plausible distributed lag function. . . . . . . . . . . . . . . 23
1.2 Thistablerepresentstheparameterestimatesfromseparateparametricdistributed
lag models and the parameter estimates from the pathway models for 48 lags (24
hours). The intermediary ' is 4 lagged time-points. yDenotes signiﬁcance at  =
0.05. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.1 SAMPLE OBSERVED DATA - This table represents the observed exposure data
over a 7 day period. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.2 SAMPLE MOVING AVERAGE DATA - This table represents the observed expo-
sure data for a 4-day moving average by id. . . . . . . . . . . . . . . . . . . . 50
2.3 SAMPLE REDUCED MOVING AVERAGE DATA - This table represents the ob-
served exposure data for a 4-day moving average by id where the missing values
were deleted. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
2.4 MOVING AVERAGE IMPUTATION IDEA - This table represents the observed
exposure data for a 4-day moving average by id. . . . . . . . . . . . . . . . . 51
2.5 MOVING AVERAGE IMPUTATION IDEA - This table represents the observed
exposure data for a 7-day moving average by id. . . . . . . . . . . . . . . . . 52
2.6 30 Unique IDs - This table represents the initial values chosen for the simulation
study. For each correlation structure, AR(1), AR(2), and ARMA(1,1), the corre-
lation coefﬁcient, moving average coefﬁcient, and variance were needed. Each
scenario produced 5 data sets. . . . . . . . . . . . . . . . . . . . . . . . . . 78
2.7 Small Deviations from AR(1) for 4-day Moving Average - This table represents
the parameter estimates for a 4-day moving average from 5 separate linear mixed
model using simulated data from the reduced, imputed, and true data sets. Linear
mixed mean models were conducted for 200 iterations. The subsequent estimates
were aggregated into means with accompanying MSE. Each model included one
continuous covariate for weekend. All of the simulation standard errors are <
0.019. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
xii2.8 Large Deviations From AR(1) for 4-day Moving Average - This table represents
the parameter estimates for a 4-day moving average from 5 separate linear mixed
model using simulated data from the reduced, imputed, and true data sets. Linear
mixed mean models were conducted for 200 iterations. The subsequent estimates
were aggregated into means with accompanying MSE. Each model included one
continuous covariate for weekend. All of the simulation standard errors are <
0.019. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
2.9 Small Deviations From AR(1) for 7-day Moving Average - This table represents
the parameter estimates for a 7-day moving average from 5 separate linear mixed
model using simulated data from the reduced, imputed, and true data sets. Linear
mixed mean models were conducted for 200 iterations. The subsequent estimates
were aggregated into means with accompanying MSE. Each model included one
continuous covariate for weekend. All of the simulation standard errors are <
0.036. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
2.10 Large Deviations From AR(1) for 7-day Moving Average - This table represents
the parameter estimates for a 7-day moving average from 5 separate linear mixed
model using simulated data from the reduced, imputed, and true data sets. Linear
mixed mean models were conducted for 200 iterations. The subsequent estimates
were aggregated into means with accompanying MSE. Each model included one
continuous covariate for weekend. All of the simulation standard errors are <
0.036. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
3.1 Health effects estimates for b  and b ! . . . . . . . . . . . . . . . . . . . . . . 94
3.2 A(top left), B(bottom left), C(top right), D(bottom right): This table represents the
parameter estimates and errors for the conﬁrmatory factor analyses (CFA) models
conducted on simulated data. Generalized linear models were conducted for 1000
iterations. The subsequent estimates were aggregated into medians. Each model
included no covariates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
3.3 A(top left), B(bottom left), C(top right), D(bottom right): This table represents the
parameter estimates and errors for the conﬁrmatory factor analyses (EFA) models
conducted on simulated data. Generalized linear models were conducted for 1000
iterations. Thesubsequentestimateswereaggregatedintomedians, and95%CI’s.
Each model included no covariates. . . . . . . . . . . . . . . . . . . . . . . . 110
3.4 A(top left), B(bottom left), C(top right), D(bottom right):This table represents the
parameter estimates and errors for the conﬁrmatory factor analyses (PCA) models
conducted on simulated data. Generalized linear models were conducted for 1000
iterations. Thesubsequentestimateswereaggregatedintomedians, and95%CI’s.
Each model included no covariates. . . . . . . . . . . . . . . . . . . . . . . . 111
3.5 A(top left), B(bottom left), C(top right), D(bottom right):This table represents the
parameter estimates and errors for the two-stage hierarchical regression models
conducted on simulated data. Generalized linear models were conducted for 1000
iterations. The subsequent estimates were aggregated into medians. Each model
included no covariates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
xiii3.6 This table represents the parameter estimates and errors for the 2-stage ”overlap”
models conducted on simulated data. Generalized linear models were conducted
for 1000 iterations. The subsequent estimates were aggregated into medians, and
95% CI’s. Each model included no covariates. . . . . . . . . . . . . . . . . . . 126
3.7 Thistablerepresentstheparameterestimatesanderrorsforthe2-stage”no-overlap”
models conducted on simulated data. Generalized linear models were conducted
for 1000 iterations. The subsequent estimates were aggregated into medians, and
95% CI’s. Each model included no covariates. . . . . . . . . . . . . . . . . . . 127
xivAcknowledgments
To begin, I would like to thank God for guiding my steps during the pursuit and
completion of the doctoral program. At each celebration and each adversity, I have
felt God’s presence by always placing me in the right environment and among the
best people.
There have been a number of key ﬁgures that have been instrumental in my devel-
opment as a researcher whom I would like to acknowledge. I truly had a ”dream
team” of advisors. Through their concerted efforts and expert tutelage, I was able
to learn and progress. I would like to recognize and thank my advisor, mentor,
and professor, Brent Coull. Of his many genuine qualities I truly appreciated his
warmth and ease. I always felt challenged but equally supported through course
work , research, and the job search. He was always welcoming, available and un-
derstanding which were irreplaceable qualities. I would like to thank Dr. Diane
Gold for all of her encouragement throughout my time in Boston. Her expertise
helped me to realize the importance of the work and how it can be used to aid
real people. To Dr. Paul Catalano, thank you for your ideas, endless energy, and
optimism which helped me to reﬁne my statistical thinking and lift my spirits. In
addition to my committee, I was lucky enough to have two academic advisors Pro-
fessor Michael Hughes and Professor Louise Ryan each of whom always showed
the utmost conﬁdence and faith in me.
ThankyoutotheinvaluablestaffintheBiostatisticsdepartmentwhokeptmemov-
ing in the right direction. They were able to act as a surrogate family for me since
I was far from home. Thank you to Aunt Jelena Follwieller, Aunt Vickie Beaulieu,
Aunt Phoebe Hackett, and my sister Rachel Boschetto. Lastly, I would like to thank
Sabrina Toomer for her generosity and love. She always treated me like family and
took care of me when I needed it-thank you so much.
Thank you to my many friends who shared this educational endeavor and toast to
our successes and continued life long friendship. Thank you Binta Beard for hold-
ing me down, your sacriﬁces and love will be valued forever. To Loni Phillip, Matt
xvAustin, Alane Izu, Shannon Stock, Roland Matsouaka, Alisa Stephens, Christina
McIntosh, and Linda Valeri thank you so much for your friendship. Thank you to
Ellen ”Kittie” Richardson and Ronald ”Kuda” Mills for your love and encourage-
ment. I needed all of you in order to be successful so I am happy to share this with
you.
Most importantly, I would like to thank my family. To my loving parents Dr.
Aguibou Mouke Yansane and Maryam Cire Fofana, thank you for your love and
support throughout my entire life. Each of you worked tirelessly to ensure that I
would become a man who is loving and of good moral character. I hope that I have
made you proud and been the blessing in your lives as you have been in mine.
My sister, Kadidja Didi Mouke Yansane, I have always admired your courage,
strength, and willingness to love. Thank you for always being there with your hu-
mor, kind words, advice, and love. Lastly, I dedicate this dissertation to the mem-
ory of my grandparents, Sekou Fofana and Aisha Cisse Fofana who passed away
before the completion of my work. I was always in their thoughts and prayers,
save a place in heaven.
xviDistributed Lag Path Analysis: Cardiovascular Effects
of Ambient Air Pollution
1Alfa I. Yansan´ e, 2;3Diane R. Gold, 1;4Paul J. Catalano,1 Brent A.
Coull
1Department of Biostatistics, Harvard School of Public Health
2Department of Environmental Health, Harvard School of Public
Health
3Department of Medicine, Brigham and Women’s
Hospital/Harvard Medical School and
4Department of Biostatistics, Dana-Farber Cancer Institute1.1 ABSTRACT
Epidemiological studies have consistently demonstrated that elevated levels of
particulate matter (PM) are associated with increased mortality and morbidity.
Further studies have demonstrated a consistent increased risk for cardiovascular
events such as myocardial infarction, stroke, cardiac arrhythmia, atherosclerosis,
and angina (Mittleman et al. 2000; Rich Q, 2005; Dockery et al., 2005; Berger et
al., 2006). In spite of prior evidence linking air pollution to these adverse health
outcomes, the underlying causal, physiological, and biological pathways are less
understood. The purpose of this article is to model and identifying the mechanis-
tic pathways of effects by conducting a path analysis within a structural equation
framework. This approach corresponds to jointly ﬁtting two generalized additive
distributed lag health outcome models, such that inferences on the health effects
can be determined through direct and indirect pathways. We compare the perfor-
mance of our approach in estimating the health effects ( changes in cardiovascular
outcomes) to that of an existing approach of modeling the outcomes separately.
Simulation results and subsequent data analysis suggest that the proposed dis-
tributed lag path analysis are effective in simultaneously estimating the health
effects from direct and and indirect path while conventional methods can not.
We employ the proposed methods in the analysis of an Exposure, Epidemiology,
and Risk Program study that investigates the effects of particulate air pollution
(PM2:5) on ST-Segment depression, T-wave alternans (TWA), and heart rate vari-
ability (HRV).
21.2 INTRODUCTION
Epidemiological studies have consistently demonstrated that elevated levels of
particulate matter (PM) are associated with increased mortality and morbidity.
Further studies have demonstrated a consistent increased risk for cardiovascular
events such as myocardial infarction, stroke, cardiac arrhythmia, atherosclerosis,
and angina (Mittleman et al. 2000; Rich Q, 2005; Dockery et al., 2005; Berger
et al., 2006). In spite of prior evidence linking air pollution to these adverse
health outcomes, the underlying causal, physiological, and biological pathways
are less understood. Identifying these mechanistic pathways will allow scientists,
researchers, and medical professionals to become more informed and thus effec-
tively focus medical interventions and treatments.
One of the primary objectives of PM research is the assessment of the health ef-
fects related to speciﬁc types of air pollution. Particulate matter, sulfur dioxide,
oxides of nitrogen, carbon oxides, and ozone have each been shown to be both
chronic and acute contributors to adverse effects on human health (Brook et al.
2004). The scientiﬁc interest of this paper is to explore the relationship between
particulate air pollution and a measure of cardiac electrical instability, T-wave al-
ternans (TWA). Further, this study seeks to explore whether pollution leads to
TWA through causing autonomic dysfunction, measured as a reduction in heart
rate variability (HRV). We hope to jointly model these phenomena to understand
interrelationships between the separate cardiac outcomes so that the effects of ex-
posure can be decomposed into direct and indirect effects (via other outcomes).
Investigations looking at the health effects of air pollution recognize that a health
outcome can be affected by exposures experienced either at the time the outcome
is measured or during some time previous to the health assessment. Accounting
3for both contemporaneous and lagged effects would give a more well rounded as-
sessment of pollution and help to avoid exposure misclassiﬁcation biases. Some
studies have shown that pollutant exposures measured at different lengths of time
have will have a varied impact on the outcome (Chuang et al. 2008). Further, the
relevant time windows may change depending on the outcome. Therefore, ap-
propriate models must account for both immediate and lagged exposure effects,
repeated measures, smoothed terms, and missing values. In this paper, we pro-
pose to develop methods that allow one to examine pathways of effects, when the
lagged effects of exposure are potentially of interest. We plan to use distributed
lag models merged within a structural equation framework to examine the rela-
tionship between air pollution and different electrical cardiac outcomes that are
known precursors to cardiovascular events.
At present, existing analyses attempt to consider temporal resolution through the
use of moving averages. The ”moving average” method of analysis calculates ex-
posure concentrations over various pre-speciﬁed intervals of time. Hence, each
model produces one effect estimate for the respective moving average. In this
modeling scheme the pollutant could be modeled as a linear or smoothed term
depending the assumed relationship. It has been recognized in the literature that
the effects of pollution are sensitive to the length of the moving averages used for
exposure measures so effects may not be fully captured.
Another issue arises when attempting to consider multiple cardiac endpoints si-
multaneously, because different lags of exposure may be most relevant for the dif-
ferent outcomes. This means that each endpoint has its own pivotal time interval
where the adverse health effects may be the highest in magnitude. If all of the
models used the same time interval and resolution, it is possible that effects may
4be seen in one outcome but not others. In this paper, we propose a path anal-
ysis that jointly ﬁts two or more distributed lag models using the pollutants as
exposures and the measures of cardiac electrical instability as outcomes. Modeling
these outcomes jointly will allow for both direct and indirect effects to be estimated
at varying time lags.
The data that motivates the proposed research comes from three analyses con-
ducted through the Exposure, Epidemiology, and Risk Program in Boston on the
effects of particulate air pollution (particulate matter, black carbon, carbon monox-
ide, ozone, nitrogen dioxide, and sulfur dioxide) on T-wave alternans and heart
rate variability. Harvard researchers have conducted a number of regression anal-
ysesusingmovingaveragesofexposureandtheseoutcomes. Pollutantsweremea-
sured from a central site while the heart outcomes were calculated by a personal
monitor at half hour intervals. There has been some exploration of potential bi-
ological pathways for this relationship such as; Direct paths through the cardio-
vascular system, blood, and lung receptors, or indirect paths through pulmonary
oxidative stress and inammatory response (Brook et al. 2004). In order to explore
the intermediate effects and their inter-relationship with other outcomes, a path-
way model can be implemented and we will introduce and derive approaches for
the implementation of such a model. Our proposed work seeks to help elucidate
the electro-physiological mechanism to complement the existing research.
This paper is organized as follows: Section 1.3 describes in detail the design and
data from a study evaluating the effects of particulate air pollution on electrical
cardiac instability. Section 1.4 presents the distributed lag model and subsequent
pathway model, while Section 1.5 discusses the direct and indirect effects of expo-
sure. Section 1.6 gives a short treatment of the Bayesian approach to estimation
5and Section 1.7 presents a simulation study to examine the effectiveness pathway
analytic model, compared to the moving average approach. Section 1.8 demon-
strates an application of the distributed lag pathway model (DLPWM) to analyze
the afore mentioned study from Exposure, Epidemiology, and Risk Program and
ﬁnally in Section 8 we discuss our ﬁndings along with implications for future path
analyses.
1.3 DATA DESIGN
1.3.1 Data Collection
The study population consisted of a recruited panel of patients with documented
coronary artery disease from the greater Boston area. Speciﬁcally, subjects were re-
cruited within route 495 (the outer most boundary of the greater Boston metropoli-
tan region) and a 40 km radius from the central pollution monitoring site. Each
subject had experienced a percutaneous coronary intervention for an acute coro-
nary syndrome or for worsening stable coronary artery disease. In each study,
patients were excluded with atrial ﬁbrillation and left bundle branch block (LBBB)
becauseoftheintenttoevaluateheartratevariabilityandST-Segmentasoutcomes.
Further exclusions included patients who had bypass graft surgery within the last
3 months because accurate interpretations of the T-wave and ST-Segment would
have been compromised. Other exclusions were active smokers, drug or alcohol
abuse problems, and those with psychiatric illness. Subjects received a home visit
within 2 to 4 weeks after the hospital discharge, followed by 3 additional visits at
approximately 3 month intervals. There were 48 subjects yielding 129 person-visits
with 6135 observations. Each patient had approximately 48 half-hour ST-segment,
6T-wave alternans, and heart rate variability (HRV) measurements taken, which
were linked with air pollution measurements at corresponding times.
The outcomes were measured using 24 hour 3 lead Holter ECG monitoring and the
electrodes were placed in modiﬁed V5 and VF positions. In the subsequent visits,
patients were given a follow-up questionnaire regarding cardiac and respiratory
symptoms, and medication use. They later received 24-hour Holter monitoring.
Ambient concentrations of particulate air matter with aerodynamic diameter less
than 2:5m (PM2:5) and black carbon (BC) were measured at the central moni-
toring site located on the roof of Countway Library, Harvard Medical School, in
downtown Boston, MA. PM2:5 concentrations were measured using Tapered Ele-
ment Oscillation Microbalance (TEOM, Model 1400A, Rupprecht and Pataschnick,
Albany, NY). Ambient BC was measured using an aethalometer. PM2:5 and BC
concentrations were summarized in half hour intervals with analysis based on half
hour, 12 hour lagged, and cumulative exposures. Indoor PM2:5 and BC measure-
ments were also taken. O3, SO2, and CO measurements were obtained using state
monitoring sites in Boston, MA.
1.3.2 Single Outcome Analyses
A ﬁrst analysis assessed the relationship between heart rate variability (HRV) and
ambient air pollution among the post coronary event patients (Zanobetti et al.
2009). Authors explored this relationship because reduced HRV has been linked to
increased risk of myocardial infarction, increased mortality in patients with heart
failure, and is a marker for fatal ventricular arrhythmia (Gold et al. 2000; Task
Force of the European Society of Cardiology the North American Society of Pac-
ing Electro-physiology, 1996). HRV was measured using four different metrics;
7standard deviation of normal-to-normal heart beat intervals (SDNN) and square
root of the mean of the squared differences between adjacent normal RR intervals
(r-MSSD), high frequency (HF), and total power (TP). The smaller the standard de-
viation in the RR intervals corresponded with lower HRV measures. The authors
used generalized additive models to control for confounding, which allowed for
the covariates to have non-linear effects on outcome. For both r-MSSD and HF, the
authors found signiﬁcant negative associations with PM2:5 and BC. There was a
tendency for the stronger r-MSSD associations to occur at longer averaging times.
The second analysis of this study was to explore the relationship between partic-
ulate pollution and T-wave alternans (Zanobetti et al. 2009). T-wave alternans
(TWA) are periodic beat to beat variations in the amplitude of the T-wave in an
electrocardiogram (ECG). It is most often measured in patients who have had my-
ocardial infarctions or other heart damage to see if they are at high risk of devel-
oping a potentially lethal cardiac arrhythmia. The shape of the T-wave could be
a key indicator of cardiac health and mortality (Nieminen et al. 2007; Stein et al.
2008). For example, inverted or negative T-waves can be a sign of coronary is-
chemia, whereas tall or tented symmetrical T-waves may indicate hyperkalemia.
TWA is also a marker of cardiac electrical instability measured as differences in the
magnitudes between adjacent waves. Increases in the previous 1 to 12 hour av-
eraged ambient PM2:5 and BC were associated with increases in TWA, with peak
cumulative effects in between 6 and 12 hours. The authors’ estimated that for a
1 unit increase in 6 hour averaged PM2:5 there was an increase of 1:7%(0:6;2:7)in
TWA.
81.4 MODEL AND NOTATION
1.4.1 Modeling Framework
An alternative to separate ”moving average” models is the distributed lag model
(DLM). Distributed lag models generalize the single time point or moving average
models because they estimate differential air pollution effects for all lagged time
points simultaneously, rather than from separate models. Our data have been col-
lected so that measurements for each pollutant have been collected for 48 separate
half-hour time lags along with the corresponding electrical cardiac instability out-
comes at those times. Therefore the data are suited for distributed lag modeling
framework.
We begin with a generalized additive distributed lag model that adjust for lagged
exposures, linear and non-linear effects of confounders, and random subject ef-
fects,
Yit = 0 +
q X
l=0
lxi;t l +
d X
j=1
fj(sitj) + 
Txit;linear + Ui + it (1.1)
whereqisthethenumberoflaggedtimepoints. Xit isthehalf-hourpollutionmea-
sureofsubjectiattimet(PM2:5)(Zanobettietal., 2000). Yit istheoutcomemeasure
of subject i at time t. The it is the error of subject i at time t and is normally dis-
tributed with zero mean and constant variance 2
. The Ui is the random coefﬁcient
due to subject i also with mean zero and variance 2
u. The vector xit;linear is a vec-
tor of variables modeled linearly and  represent the effect estimates. The overall
impact of a unit change in in exposure over q days is given by 
q
t=0l (Schwartz et
al., 2000). Due to collinearity, it is necessary to constrain the l to be a polynomial
9or spline function of l. For each l there were three different options utilized. They
will be represented by the following equations.
Option 1(Parametric):
l =
p X
r=1
rl
r
where 0  l  q
Option 2 (Thin-Plate Spline)(Crainiceanu et al., 2005):
l =
2 X
r=1
rl
r +
K X
k=1
kjl   kj
3
where 0  l  q and
Option 3 (Truncated Spline):
l =
p X
r=1
rl
r +
K X
k=1
k(l   k)
p
+
where 0  l  q and
(l   k)
p
+ =
(
(l   k)p if l  k
0 if l < k
;
where 1, :::, K is a set of K distinct numbers between 0 and q. l is a piecewise
pth degree polynomial in l, with join points (knots) at the k. The k are coefﬁcients
associated with the basis function (l   k)
p
+.
Each smooth function fj can be estimated using a penalized spline of degree p
10(Carroll et al., 2003):
fj(sitj) =
p X
c=1
j;cs
c
itj +
Kj X
k=1
!j;k(sitj   j;k)
p
+
The sijt is the confounder variable for the ith subject, the jth variable modeled as a
smooth function at time t. The j;c is the coefﬁcient for jth smoothed term. While
the !j;k are the coefﬁcients corresponding to the basis function (sitj   j;k)
p
+ for
the jth smoothed variable. Each smoothed term can be expressed in the form of a
linear mixed model with both ﬁxed and random terms.
1.4.2 Distributional Assumptions
Model (1.1) can be simpliﬁed through matrix representations below:
Y = XLag + ZLagu +
Pd
j=1 Xsmooth;jj +
Pd
j=1 Zsmoothwj + XLinear + 
 = [0;0;1;:::;p]
T
 = [0;1;:::;p]
T
u = [U1;U2;:::;Um]
T
 = [1;2;:::;K]
T
wj =

!1;!2;:::;!Kj
T
 = [1;2;:::;b]
T
Let p represent the the polynomial degree, let m represent the total number
11of distinct subjects such that 1  i  m. , and let ni represent the number of
observations at time t. By concatenating the model further and using the fact that
the spline coefﬁcients can be modeled as random effects, the above equation can
be reduced to the simple mixed model (1.2) in the following form:
Y1 =

XLag XSmooth XLinear

2
6 6 6 6
4



3
7 7 7 7
5
+

ZLag ZSmooth

2
6
4
u
w
3
7
5 +  (1.2)
Y1 = X1 + Zb1 +  (1.3)
Cov
2
6
4
b

3
7
5 =
2
6
6 6 6 6 6
6
4
2
uI 0 0 0
0 2
I 0 0
0 0 2
!;jI 0
0 0 0 2
I
3
7
7 7 7 7 7
7
5
The form of this model could be applied to other outcomes, for example ST seg-
ment. The model would be analogous to the one above including the same con-
founders but with a different outcome.
Y2 = X2 + Zb2 + ; (1.4)
1.4.3 The Pathway Analytic Model
Path analysis can be used to test theoretical models that specify causal relation-
ships between a number of observed variables (Hatcher, 1994). Structural equa-
12tion models (SEM’s) are a set of ﬂexible models that enable the modeling of mul-
tivariate data for path analyses. SEM’s can handle both simple and hierarchical
modeling structures (Sanchez et al., 2005). An essential tool for SEM’s is the path
diagram or directed acyclical graph (DAG) that details causal relationships graph-
ically. Each variable is represented by its own box. Single-headed arrows represent
causal relationships between two different variables. In Figure 1.1, the x variable
represents the independent variable or antecedent variable, predicted to precede
and have a causal effect on y. The y box represents the consequent variable or the
dependent variable. The straight, single-headed arrow is generally used to repre-
sent a directional causal path in a path diagram while also detailing the statistical
model that describes the relationship. The z variable can be considered an inter-
mediate (mediator) variable because it is on the causal pathway from x to y and it
is caused by x.
Through normal likelihood theory, estimation of parameters, conﬁdence intervals,
and p-values can be calculated. Standard approaches to pathway analysis usually
make the assumption that the variables of interest are normally distributed. Sub-
sequently, direct paths have point and interval estimates while indirect paths are
theproductoftheestimateoftheindependentvariabletotheintermediatevariable
andthatfortheassociationbetweenestimateoftheintermediatevariabletothede-
pendent variable. In the normal theory case, these parameters could be estimated
using to least squares equations. The following example is a simple illustration of
the modeling scheme.
Let y be the outcome variable, x be the independent variable, and z be the
intermediate variable whereby 2 denotes the linear association between x and y,
1 denotes the linear association between x and z, and 3 the linear association
13between z and y. The DAG for the model is as follows:
z = 0 + x1 + ez (1.5)
y = 00 + x2 + z3 + ey (1.6)
..
 
θ1  θ3 
 
θ2 
                      x                        y 
                      z 
Figure 1.1: General Form
By substituting the value z from equation (1.5) into equation (1.6) we have the
resulting equation that allows one to estimate 13 and 2.
y = 00 + 03 + x2 + x13 + ez3 + ey (1.7)
This method is effective when the variables are normally distributed (Gajewski et
al., 2006). There is also the question of calculating the appropriate standard errors
using this method because the standard errors for 1 and 3 are correlated. There-
fore, there is a natural congruence between the directed acyclical graph (DAG) and
its corresponding model.
Extending this basic conceptual structure using generalized distributed lag mod-
els we present Figure 1.2 below as a potential directed acyclical graph (DAG). We
14propose that the GADLMs below are an accurate reﬂection of the DAG and will
be able to estimate the direct effects of pollutant on T-wave alternans as well as the
indirect effects through the intermediary HRV. Equation (1.8) represents a model
that estimates the direct effects of the exposure (xit) on outcome 1 (Y1;it) where the
1;l are the parameters of interest. While model (1.9) estimates the effect of expo-
sure (xit) on the second outcome (Y2;it) through the intermediary (Y1;it). The 2;l
are the distributed lag function for the direct effects between T-wave alternans and
the pollutant. The 'l represents the coefﬁcient of the intermediate outcome (Y1;it).
Hence, through the SEM framework model (1.9) accounts for multiple endpoints
on the causal pathway and yields interpretable direct and indirect effects.
..
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Figure 1.2: DAG for Air pollutant exposure
Y1;it = 1;0 +
q X
l=0
1;lxi;t l +
d X
j=1
fj(sitj) + 
T
1 wit + U1;i + 1;it; (1.8)
Y2;it = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'lY1;i;t l +
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it; (1.9)
151.5 DIRECT AND INDIRECT EFFECTS
1.5.1 Interpretation
In a broad sense, the relationship between an exposure of interest and an outcome
can be singular or multifactorial. We are interested in quantifying the relationship
through detailing the magnitude, direction, and causal pathway. A direct effect is
deﬁned as a link between an exposure and outcome. Given the previous DAGs,
the direct effects are represented by a single arrow with no intermediaries. On the
other hand an indirect effect is the link between an exposure and outcome that con-
sist of intermediaries on the pathway. Therefore, more than one arrow is needed
to describe the relationship. This is signiﬁcant because researchers will be able to
explore whether the effects of a pollutant can be seen directly or indirectly through
an intermediary. This will illuminate many questions regarding the electrophysio-
logical pathway between pollutants and electrical cardiac outcomes as well as test
for interrelationships. For example, in our current data set, HRV precedes TWA
on the electro-physiological pathway and researchers would like to investigate the
scientiﬁc trail where the pollutants are the most inﬂuential.
Using ﬁgure 1.2 as the model DAG, we estimate the direct effect between outcome
(TWA) and the exposure (pollutant) with a set of parameters 2;l represented by
a smoothed curve, and the indirect effects between the outcome variable and the
exposure through the mediating variable is represented by another curve proven
below:
Y1;it = 1;0 +
q0 X
l0=0
1;l0xi;t l0 +
d X
j=1
fj(sitj) + 
T
1 wit + U1;i + 1;it; (1.10)
16Y2;it = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'lY1;i;t l +
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it (1.11)
Now we substitute equation (1.10) into equation (1.11) and rearrange the terms.
Y2;it = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'l
"
1;0 +
q0 X
l0=0
1;l0xi;t l0 l +  + 1;i;t l;
#
+
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it
Since we are only interested in the direct and indirect effects of exposure and their
interpretations we will use the following as our model of interest where [] repre-
sents the other terms/confounders in the model after some.
Y2;it =
"
q X
l=0
2;lxi;t l +
q X
l=0
q0 X
l0=0
'l1;l0xi;t l0 l
#
+ []:
=
"
q X
l=0
2;lxi;t l +
q+q0 X
k=0


kxi;t k
#
+ []
The 2;l parameters represent the set of direct effects of lagged exposure on our
outcome and
where 
k =
P
l+l0=k ['l1l0] represents the indirect effect of the lagged exposure on
outcome.
171.6 ESTIMATION
Standard distributed lag models (DLM’s) could be ﬁt using maximum likelihood
methods by including all covariates in a generalized linear-mixed model. ML
methods require large sample sizes for asymptotic optimality of the resulting ML
estimators. Since we have 48 lagged exposures to be included in the model, these
methodsmaynotbeoptimal. Further, thenumberofparameterestimatesincreases
when conducting the pathway analyses to account for the new effects.
We propose a non-informative Bayesian approach to modeling these distributed
lag data. We wish to estimate the effect of PM2:5 on two separate cardiovascular
outcomes simultaneously. The estimates will be represented by r for r = 1;:::;p.
Non-informative priors are proposed for each parameter so that the estimates are
primarily data driven. Each  is distributed as follows:
  N(0;	)
Where 	 = 10;000. An informative approach could have been done as well but
more data from previous studies would have been needed.
1.7 SIMULATION STUDY
We conducted a simulation study to examine the effectiveness of DLM pathway
model to estimate the changes in TWA and HRV. We would also like to perform a
direct comparison of estimates between a moving average, parametric, and semi
parametric approaches. The intended outcomes, the lagged exposure, and the co-
18efﬁcients must be simulated under varying assumptions in order to get a complete
picture of the model effectiveness while decomposing the exposure-outcome re-
lationship. We began with 50 subjects yielding 100 person-visits with 5000 total
observations. There were also 50 measurements taken for each of the 100 subjects
and 50 lagged time-points created to mimic those in the real data.
1.7.1 Simulating Lagged Data
To simulate exposure, we generated 50 PM2:5 exposure variables lagged by half
hour intervals from X  N(x;x). We assumed,
x =
2
6 6 6 6
6 6 6 6 6
6
4
2
x  2 ::: 49
 2
x  ::: 48
2  2
x ::: 47
. . .
. . .
. . . ... . . .
49 48 47 ::: 2
x
3
7 7 7 7
7 7 7 7 7 7
5
;
where  = 0:4 to reﬂect the fact that PM2:5 measurements taken at closer intervals
are more highly correlated. 2
x = 1 and x = 5 were taken from averages in the
real data.
1.7.2 Simulating Outcome 1
Next, we picked initial values under varied conditions for  that were also chosen
based estimates from the models of the real data. Each l was then calculated
using the afore mentioned formula: l =
Pp
r=1 rlr where p= 3 representing a cubic
19polynomial spline. These values were needed to simulate the direct effect between
Y1(HRV) and X(PM2:5). Y1 was simulated from the following distribution:
Y1jX;1  N(
q0 X
l0=0
1;l0xi;t l0;
2
y1)
1.7.3 Simulating Outcome 2
Our next task was to simulate Y2 which reﬂects the indirect effect PM2:5 and TWA.
In addition to choosing initial values for 2, initial values for ' were designated as
they represent the intermediary effects between HRV and TWA. Since HRV only
acts on TWA for a short period of time, the lagged relationship between HRV and
TWA only spanned 2 time points. Although for thoroughness in understanding
we conducted simulation with 6 intermediary time points. The intermediary time
pointvaluesdenotedbythevariable'l andgivenbythefunction, '[i] = 0:1 :001i2
for i = 1;:::;6. Y2 was then simulated from the following distribution:
Y2jY1;2  N(
q X
l=0
2;lxi;t l +
q X
l=0
'lY1;i;t l;
2
y2)
1.7.4 Simulation Path Model
Table 1.1 gives the assumed true values used for each simulated scenario. They
represent distinct, biologically plausible combinations of distributed lag functions
for HRV and TWA. Using the values of  in table 1.1, the corresponding health
effect estimates l are calculated. Next, the X;Y1, and Y2) values are generated for
100 data sets on which the distributed lag pathway model was conducted. Each
20path model only included lagged exposure variables and lagged Y2 values. The
form of the simulated path model is as follows:
Y1;it = 1;0 +
q0 X
l0=0
1;l0xi;t l0 + U1;i + 1;it; (1.12)
Y2;it = 2;0 +
q X
l=0
2;lxi;t l + U2;i + 2;it (1.13)
where l =
Pp
r=1 rlr. Both the parameters and hyper parameters were given the
following non-informative priors.
  N(0;100000)
Ui  N(0;
2
u)

2
u  IG(0:01;0:01)

2
y  IG(0:01;0:01)
For each data set, the posterior distribution is estimated using MCMC methods
using 10,000 iterations and subsequently keeping 1,000 posterior values. The mix-
ing of each model is checked visually by the trace plots to see if convergence was
achieved. Next, the median and point-wise 95% credible interval of each lagged
time point are calculated for each of the 100 sets of posterior effect estimates.
211.7.5 Simulation Results
Each simulated pathway model will be designated by 4 output graphs where the
X-axis represents the lagged time points and the Y-axis is the magnitude of the pos-
terior effect estimate. Each plot includes a true (red curve) and estimated (black
curve) distributed lag function and 95% conﬁdence bands (black) for the relation-
ship between: 1) PM and HRV (1;l), 2) PM and TWA (2;l), 3) HRV and TWA
('l), and 4) Indirect Effect of PM on TWA through HRV(
l ). The blue curve in the
3rd position plot represents a reduced setting on the magnitude of the relationship
between HRV and TWA. The blue curve in the 4th position gives the indirect asso-
ciation of PM2:5 on TWA through HRV for the afore mentioned reduced setting.
Figure 1.3 represents the ﬁrst simulation setting model due to its biological pattern.
In the literature we see that HRV has a negative relationship with PM2:5 and TWA
has a positive relationship with PM2:5. For this simulation scenario we note that
the estimated distributed lag function quite accurately estimates the true DLF and
is also within 95% credible limits in all 4 graphs.
The pathway model for the ﬁrst simulation shows that the relationship between
PM2:5 and HRV is negative. Early lags reﬂect the highest effects while later lags
move towards 0. The relationship between PM2:5 and TWA is positive with most
of the effect occurring at earlier lags as well. The distributed lag function for the
indirect effects (
l ) are almost identical to the distributed lag function between
PM2:5 and HRV except for the ﬁrst 12 time points. As we would expect, the indi-
rect effect depends on the magnitude of the distributed lag function for the rela-
tionship between HRV and TWA given by 'l, and our procedure is able to appro-
priately separate out these direct and indirect effects. Other simulation scenarios
were completed and the conclusions were similar.
22Model Initial-0 Initial-1 Initial-1 Initial-3
Model 1:
HRV(1) -0.01 0.0011 -0.000041 0.00000043
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Model 2:
HRV(1) 0.00 0.00 0.00 0.00
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Model 3:
HRV(1) -0.01 0.0011 -0.000041 0.00000043
TWA(2) 0.0 0.00 0.00 0.00
Model 4:
HRV(1) -0.01 0.0011 -0.000041 0.00000043
TWA(2) 0.001 -0.0005 0.00006 -0.000001
Model 5:
HRV(1) 0.01 -0.0005 0.00006 -0.000001
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Model 6:
HRV(1) 0.01 -0.00055 0.000041 0.000001
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Model 7:
HRV(1) -0.001 0.00015 -0.000005 0.0000002
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Model 8:
HRV(1) 0.01 0.0011 0.000041 0.00000043
TWA(2) 0.01 -0.0011 0.00004 -0.00000043
Table 1.1: This table represents the initial values chosen for the simulation study. For each model,
4 initial values were chosen for both HRV and TWA. Each model corresponds to a distinct plausible
distributed lag function.
1.8 DATA ANALYSIS
1.8.1 Prior Elicitation
Given the motivating heart data, DLMM models were ﬁt using the same con-
founders as the initial analysis described in Section 1.2. The following model was
used for this analysis:
Y1;it = 1;0 +
q0 X
l0=0
1;l0xi;t l0 + 
T
1 wit + U1;i + 1;it; (1.14)
23..
Figure 1.3: Model 1-Regular HRV; Regular TWA
where:
1;l =
p X
r=1
rl
r
where 0  l  q
We used the above parametric parameterization of 1;l for p=2, 3, and 4 which
corresponds to quadratic, cubic, and quartic single pollutant models. We also at-
tempted to use the ”Thin-plate spline” and ”Truncated spline” parameterizations
for 1;l but the results were less stable. Each model adjusted for subject and day
24of the week as indicator variables while average heart rate, mean temperature,
hour of the day using quadratic effects. Quadratic effects were chosen for these
variables because univariate generalized additive models were run and quadratic
effects seemed to be a plausible approximation. Lastly, numerical date was con-
trolled for using the following parameterization:
date1 =
sin(2date)
T , date2 =
cos(2date)
T
To conduct this Bayesian analysis we utilized Markov Chain Monte Carlo meth-
ods MCMC to estimate the parameters for the DLM using the R statistical pack-
age (The Comprehensive R Archive Network: http://cran.r-roject.org/). The
”R2Winbugs” function was used so that Winbugs could be accessed within the R
platform (Crainiceanu et al., 2005). Since our model was ﬁt in the Bayesian setting,
we assigned non-informative priors for the model parameters.
  N(0;100000)
ui  N(0;
2
u)
!j  N(0;
2
!j)

2
u  IG(0:01;0:01)

2
!j  IG(0:01;0:01)

2
y  IG(0:01;0:01)
Each model was run using a burn-in period of 20,000 iterations. The convergence
of each estimated parameter was checked by visual inspection of the trace plots.
We kept 5,000 posterior samples thinned by 5 for each of the 49 lagged estimates.
25The total effect of a particular pollutant over q hours was calculated by summing
over the lagged coefﬁcients given by the posterior samples. This yielded 5,000
posterior samples of the total pollutant effect over 24 hours so that medians and
conﬁdence intervals could be produced.
1.8.2 Health effects analysis
Heart Rate Variability
Figure 1.4 is a plot of the distributed lag function for the relationship between HRV
(measured as r-MSSD) and PM2:5. Each graph represents a quadratic, cubic, and
quartic parameterization of this relationship. Subject, day of the week, average
heart rate, mean temperature, hour of the day, and were the included confounders.
Figure 4 reveals that the effect of PM2:5 on heart rate variability has a curvilin-
ear shape that is concave and the effect is mostly negative across the three model
versions. The overall impact of a unit change in PM2:5 over 48 lags (24 hours)
was associated with a -0.00872 (-0.013, -0.0049) reduction in HRV for the quadratic
model, -0.0085 (-0.0124, -0.0046) reduction in HRV for the cubic model, and -0.0084
(-0.0124, -0.0042) reduction in HRV for the quartic model. This shows consistency
across the parameterization. These results are consistent with the moving average
results of Zanobetti et al. 2000.
T-wave alternans
Figure 1.4 also contains plots of the distributed lag function for the relationship
between TWA and PM2:5. Each plot represents a quadratic, cubic, and quartic
26(a) Quadratic Model (HRV) (b) Cubic Model (HRV) (c) Quartic Model (HRV)
(d) Quadratic Model (TWA) (e) Cubic Model (TWA) (f) Quartic Model (TWA)
Figure 1.4: Top Row: SINGLE OUTCOME MODEL HRV - Each graph represents the DL function
of the relationship between PM2:5 and HRV adjusting for subject, day of week, average heart rate,
mean temperature, hour of the day, and date. Bottom Row: SINGLE OUTCOME MODEL TWA -
Each graph represents the DL function of the relationship between PM2:5 and TWA adjusting for
subject, day of week, average heart rate, mean temperature, hour of the day, and date.
27parameterization of this relationship. Figure 5 reveals that the effect of PM2:5 on
TWA has a curvilinear shape that begins with a highly positive effect for early lags
and approaches zero for later lags. The overall impact of a unit change in PM2:5
over 48 lags (24 hours) was associated with a 0.0023 (0.00042, 0.00421) increase in
TWA for the quadratic model, 0.0030 (0.0012, 0.0050) increase in TWA for the cubic
model, and 0.0032 (0.0013, 0.0051) increase in TWA for the quartic model. Each
of the estimates show a signiﬁcant and positive relationship between PM2:5 and
TWA-. Zanobetti et al., 2009 shows that with increasing moving averages, there is
an increase in the TWA which means that the two approaches are in accord (See
Appendix Figure 8).
1.8.3 Path Analysis
The path analyses in Figures 1.5, 1.6, and 1.7 reﬂect the real data from the Expo-
sure, Epidemiology, and Risk Program in Boston. The outcomes of speciﬁc interest
are HRV (measured through r-MSSD) , TWA, and the exposure is PM2:5 just as in
sections 1.8.1 and 1.8.2. In the previous sections, the distributed lag models were
used to show the univariate relationships between exposure and outcome control-
ling for potential confounders. In the current section, the path models seek to
estimate these effects simultaneously and in aggregate along with the inclusion of
an indirect effect. The path model is included below:
Y2;it = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'lY1;i;t l + 
T
2 w1;it + U2;i + 2;it; (1.15)
where Y1;i;t l is given by:
28..
Figure 1.5: QUADRATIC PATH MODEL - Clockwise : 1) PM2:5 on HRV, 2) PM2:5 on TWA, 3)
PM2:5 on TWA indirectly through HRV, and 4) HRV on TWA.
Y1;it = 1;0 +
q X
l=0
1;lxi;t l + 
T
1 wit + U1;i + 1;it; (1.16)
In order for the path model to be fully implemented a lag structure needed to be
created for Y1;i;t l (HRV). 4 lags were used to describe the relationship between
HRV and TWA because the largest effects were seen within that time. As a result
of the creation of these new lags 4 observations per study id had to be removed.
We also investigated 8 lags for the HRV vs.TWA relationship and the results were
comparable. Figures 1.5 - 1.7 show the distributed lag function for the following
relationships in a clockwise fashion: 1) PM2:5 on HRV, 2) PM2:5 on TWA, 3) PM2:5
on TWA indirectly through HRV, and 4) HRV on TWA. Each plot consists of a
medianposteriorcurveandacorresponding95%credibleinterval. Thedistributed
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Figure 1.6: CUBIC PATH MODEL - Clockwise : 1) PM2:5 on HRV, 2) PM2:5 on TWA, 3) PM2:5
on TWA indirectly through HRV, and 4) HRV on TWA.
lag functions in position 1) and 2) from each of the path models are similar in shape
to their separate model counterparts respectively.
In Table1. 2 we see the overall estimated effects of the separate models juxtaposed
with overall estimated effects of the pathway models. We found signiﬁcant asso-
ciations between HRV and PM2:5 in both the separate and pathway models in all
cases, and the overall estimates were similar. All of the estimates show a negative
relationship whereby increases in PM2:5 are associated with decreases in HRV. Fur-
ther, the distributed lag functions of the quadratic, cubic, and quartic path models
are similar. Signiﬁcant associations were found between TWA and PM2:5 in both
the separate and pathway models in all cases as well. All of the estimates show
a positive overall relationship whereby increases in PM2:5 are associated with in-
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Figure 1.7: QUARTIC PATH MODEL - Clockwise : 1) PM2:5 on HRV, 2) PM2:5 on TWA, 3) PM2:5
on TWA indirectly through HRV, and 4) HRV on TWA.
creases in TWA. Once again, the distributed lag functions of the quadratic, cubic,
and quartic path models are similar. The effect estimates from the separate models
were attenuated by approximately 37-46% in comparison with the pathway model
estimates for TWA. The direct and indirect effects are intrinsically included when
conducting the single outcome models, which leads to the dimmed effect estimate.
The indirect effects cannot be estimated in the separate models because they would
not have been simultaneously done. The pathway model estimates a negative
overall effect for the indirect relationship between PM2:5 and TWA through the
intermediary HRV in the quadratic, cubic, and quartic cases. The overall impact of
a unit change in PM2:5 over 48 lags (24 hours) is associated with a -0.0086 (-0.0126,
-0.0046), -0.0085 (-0.0124, -0.0044), and -0.0083 (-0.0124, -0.0042) decreases in HRV
31Outcome Quad. Separate Model Est. and 95% CI Quad. Path Model Est. and 95% CI
HRV(1;l): -0.00872 (-0.013, -0.0049)y -0.0086 (-0.0126, -0.0046) y
TWA(2;l): 0.0023 (0.00042, 0.00421)y 0.0043 (0.0025, 0.0063)y
Indirect() : N/A -0.0014 (-0.0022, -0.00071) y
Outcome Cubic Separate Model Est. and 95% CI Cubic Path Model Est. and 95% CI
HRV(1;l): -0.0085 (-0.0124, -0.0046)y -0.0085 (-0.0124, -0.0044)y
TWA(2;l): 0.0030 (0.0012, 0.0050)y 0.0050 (0.0031, 0.0069)y
Indirect(): N/A -0.0014 (-0.0021, -0.00065) y
Outcome Quartic Separate Model Est. and 95% CI Quartic Path Model Est. and 95% CI
HRV(1;l): -0.0084 (-0.0124, -0.0042)y -0.0083 (-0.0124, -0.0042)y
TWA(2;l): 0.0032 (0.0013, 0.0051)y 0.0051 (0.0032, 0.0070)y
Indirect(): N/A -0.0015 ( -0.0023, -0.00070)y
Table 1.2: This table represents the parameter estimates from separate parametric distributed
lag models and the parameter estimates from the pathway models for 48 lags (24 hours). The
intermediary ' is 4 lagged time-points. yDenotes signiﬁcance at  = 0.05.
for the quadratic, cubic, and quartic models respectively. The overall impact of
a unit change in PM2:5 over 48 lags (24 hours) is associated with a 0.0043 (0.0025,
0.0063), 0.0050 (0.0031, 0.0069), and 0.0051 (0.0032, 0.0070) increase in log(TWA) V
for the quadratic, cubic, and quartic models respectively. Finally, the overall indi-
rect impact of a unit change in PM2:5 over 48 lags (24 hours) is associated with a -
0.0014 (-0.0022, -0.00071), -0.0014 (-0.0021, -0.00065), and -0.0015 ( -0.0023, -0.00070)
decrease in log(TWA) V through HRV for the quadratic, cubic, and quartic mod-
els respectively. We see that the distributed lag function for the indirect effects
mimics the the DL function for HRV except for the the ﬁrst 6 time points.
This study provides evidence that exposure to ambient air pollution in the form
of PM2:5 increases cardiac electrical instability over a 24 hour period capturing
effects during sleep, morning hours, as well as normal activity. This ﬁnding offers
a possible parsing of the mechanisms that lead to cardiac events.
321.9 DISCUSSION
In this paper, we considered methods to assess speciﬁc health effects of PM2:5 as
they relate to electrical cardiac outcomes. One objective was to detail the path
by which particulate matter effected cardio-vascular outcomes and to parse out
the effects between multiple outcomes. In a simulation study and corresponding
analysis, we showed that the path way distributed lag model was able to estimate
the effects of particulate matter on multiple outcomes simultaneously with relative
accuracy when compared to separate models.
As an alternative to the moving average approach and the separate lag model
method initially which allowed us to model a function rather than a single point
estimate at different times. The advantage is that the relationship can be viewed
with a ﬁne, continuous resolution over the entire time period. We proposed a path
way distributed lag model to account for multiple effects at different time intervals
simultaneously. Simulations suggest that the proposed distributed lag pathway
model is effective in separating the effects of multiple outcomes, which when done
separately could be biased. The pathway models showed that the relationship be-
tween PM2:5 and TWA-MAX was underestimated by greater than 37%(37-46%)
compared to models being separately done. The pathway model was able to esti-
mate the relationship between PM2:5 and HRV with relative accuracy. All of the
indirect effects were signiﬁcant which lends evidence to the hypothesis that there
are alternate/complementary/indirect biological pathways that can inﬂuence the
direct relationship. Our results suggest that the magnitude of the indirect effect
was highly dependent on the direction and length of the intermediate distributed
lag function of HRV.
We also demonstrated the ﬂexibility of the pathway approach to accommodate
33different parametric modes such as quadratic, cubic, and quartic, set at different
initial values, and remain consistent/accurate in estimation. The overall estimates
were similar when moving from quadratic to cubic, from cubic to quartic, and
from quadratic to quartic and the highest effects ere seen at early lags. In our
data set and subsequent simulations, the distributed lag function for HRV nearly
always mimicked the indirect effect distributed lag function although the effect
was slightly attenuated. The changes in the DL function of the indirect effect
would occur most notably in the ﬁrst 4,8, or 12 time points depending on the
number of lags in the HRV variable. Lastly, when including lagged HRV as a
confounder in the single outcome models, the estimates remain the same as those
given in the pathway models although the indirect effects could not be estimated.
One limitation of these analyses is the time resolution of HRV and TWA. There
were half-hour periods over which the outcomes measures for HRV and TWA
were averaged. Therefore if shorter time resolution were needed for HRV in
deﬁning the pathway toTWA the model may not pick it up. Therefore it would be
beneﬁcial to not only have an increased sample size but also a much more ﬁnely
measured time resolution which would allow effects to seen at the appropriate
time points.
341.10 APPENDIX
1.10.1 Proof Direct and Indirect Effects
STit = 1;0 +
q0 X
l0=0
1;l0xi;t l0 +
d X
j=1
fj(sitj) + 
T
1 wit + U1;i + 1;it
TWAit = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'lST1;i;t l +
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it
Now we substitute STit into equation for TWAit and rearrange the terms.
TWAit = 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'l
"
1;0 +
q0 X
l0=0
1;l0xi;t l0 l +  + 1;i;t l;
#
+
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it
= 2;0 +
q X
l=0
2;lxi;t l +
q X
l=0
'l [1;0] +
q X
l=0
'l
"
q0 X
l0=0
1;l0xi;t l0 l
#
+
q X
l=0
'l
"
d X
j=1
fj(si;t l;j)
#
+
q X
l=0
'l


T
1 wi;t l

+
q X
l=0
'l [U1;i] +
q X
l=0
'l [1;i;t l]
+
d X
j=1
gj(sitj) + 
T
2 w1;it + U2;i + 2;it
=
"
2;0 +
q X
l=0
'l1;0
#
+
"
q X
l=0
2;lxi;t l +
q X
l=0
q0 X
l0=0
'l1;l0xi;t l0 l
#
+
+
"
q X
l=0
d X
j=1
'lfj(si;t l;j) +
d X
j=1
gj(sitj)
#
+
"
q X
l=0
'l
T
1 wi;t l + 
T
2 w1;it
#
+
"
q X
l=0
'lU1;i + U2;i
#
+
"
q X
l=0
'l1;i;t l + 2;it
#
35Since we are only interested in the direct and indirect effects of exposure and their
interpretations we will use the following as our model of interest where [] repre-
sents the other terms/confounders in the model.
TWAit =
"
q X
l=0
2;lxi;t l +
q X
l=0
q0 X
l0=0
'l1;l0xi;t l0 l
#
+ []:
The 2;l parameters represent the direct effects of lagged exposure on our outcome.
Next we will expand the expression of the double sum to get the indirect effect of
exposure on our outcome Taking this expression we have:
q X
l=0
q0 X
l0=0
'l1;l0xi;t l0 l = '0 [10xi;t 0 + 11xi;t 1 + 12xi;t 2 +  + 1q0xi;t q0]
+ '1 [10xi;t 1 + 11xi;t 2 + 12xi;t 3 +  + 1q0xi;t q0]
+ '2 [10xi;t 2 + 11xi;t 3 + 12xi;t 4 +  + 1q0xi;t q0]
. . .
+ 'q [10xi;t q + 11xi;t q 1 + 12xi;t q 2 +  + 1q0xi;t q q0]
By distributing and rearranging terms we have:
36= ['010xi;t 0 + '011xi;t 1 + '012xi;t 2 + '013xi;t 3 +  + '01q0xi;t q0]
+ ['110xi;t 1 + '111xi;t 2 + '112xi;t 3 + '113xi;t 4 +  + '11q0xi;t 1 q0]
+ ['210xi;t 2 + '211xi;t 3 + '212xi;t 4 + '213xi;t 5 +  + '21q0xi;t 2 q0]
. . .
+ ['q10xi;t q + 'q11xi;t q 1 + 'q12xi;t q 2 + 'q13xi;t q 3 +  + 'q1q0xi;t q q0]
=

0 z }| {
['010]xi;t 0 +

1 z }| {
['011 + '110]xi;t 1 +

2 z }| {
['012 + '111 + '210]xi;t 2
+  + ['01q0 + '11;q0 1 +  + 'q10]xi;t q q0
= 

0xi;t 0 + 

1xi;t 1 + 

2xi;t 2 + 

3xi;t 3 + 

4xi;t 4 +  + 

q+q0xi;t q q0
=
q+q0 X
k=0


kxi;t k
where 
k =
P
l+l0=k ['l1l0] which represents the indirect effect of the lagged expo-
sure on outcome. The ﬁnal models is as follows:
37TWAit =
Intercepts
z }| { "
2;0 +
q X
l=0
'l1;0
#
+
DirectandIndirectEffects
z }| { "
q X
l=0
2;lxi;t l +
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381.10.2 Simulations Scenarios 1-7
..
Figure 1.8: Model 2-No Effect HRV; Regular TWA
39..
Figure 1.9: Model 3-Shifted Effect HRV; Regular TWA
40..
Figure 1.10: Model 4-Regular HRV; Shifted Effect TWA
41..
Figure 1.11: Model 5-Heavy end Effect HRV; Regular TWA
42..
Figure 1.12: Model 6-Positive Effect HRV; Regular TWA
43..
Figure 1.13: Model 7-Positive Effect HRV (downward); Regular TWA
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Epidemiological studies have shown that an individual’s cumulative exposure to
pollutants is a result of both acute and lagged effects. Therefore, accurate measures
of exposure patterns are instrumental to conducting a health effects analysis. The
variablestraditionallystudiedinenvironmentalepidemiology, suchasexposureto
ambient outdoor pollution, indoor pollutants, and environmental hazards are of-
ten subject to measurement errors. Although, there has been considerable research
conducted on missing data and measurement error, little work has been done to
address missing data in the moving average time series setting. In this article we
propose a new regression calibration approach that focuses on estimating missing
moving averages by conditioning on the observed data. We compare via simu-
lation the performance of our ”moving average” approach in estimating missing
exposure data to that of 2 existing approaches, a daily value imputation method
and a reduced method where missing observations are deleted. Simulation results
suggest that the proposed regression calibration using the moving average lead to
robust and less biased estimates of the parameters of interest.
462.2 INTRODUCTION
Variables commonly studied in environmental epidemiology, such as exposure to
ambient outdoor pollution, indoor pollutants, and environmental hazards are of-
ten subject to measurement error. Such pollutants have many sources of variability
such as instrument error, recording error, and missing observations. Misclassiﬁca-
tion of exposures is a well-recognized inherent limitation of panel studies linking
diseases to the environment. For many agents of interest, exposures have both spa-
tialandtemporalinﬂuences. Asaresult, itisoftenadauntingtaskforinvestigators
to accurately represent the relevant exposures for each participant. Researchers
continue to take steps to control the consequences of measurement error through
conscientious study designs and data collection, and by making adjustments for
the error in the statistical analyses (Zeger et al., 2000).
In many panel studies, access to ambient exposure information for several con-
secutive periods (e.g. days, months, years previous) are available due to central
site monitoring but the precision of the measurements have inconsistencies. Al-
ternatively, access to indoor exposure measurements requires more resources for
accurate and complete data collection, include increased participant burdens, and
require higher costs for the longer term measurements. As the issue of exposure
errors has become well recognized in the literature, researchers have shown that
human activities impact the timing, location, and degree of pollutant exposure.
According to the National Human Activity Pattern Survey (NHAPS), respondents
reported spending an average of 87% of their time in enclosed buildings and about
6% of their time in enclosed vehicles (Klepeis N et al., 2001). Therefore human
behaviors are key contributors in explaining exposure variations. These statistics
underscoretheneed todetailpollutantexposures usingindoormethodsso thatthe
47most comprehensive arch of vulnerability and susceptibility could be captured. In
this paper, we seek to develop methods that correct covariate/exposure measure-
ment error due to missing data through the use of regression calibration.
Existing analyses, when confronted with missing indoor exposure data may at-
tempt to either remove participants/observations with incomplete data or conduct
regression calibration methods by imputing the individual exposure observations.
Since indoor exposure data tend to be sparse, discarding valuable observations
may not be an optimal option. In this paper, we propose to develop methods that
allow one to perform imputation methods on the moving averages of unobserved
covariate exposures conditional on the observed data. This is achieved using large
sample methods that require statistical models for the distribution of exposure X
conditional on observed covariates. In addition to these considerations, time series
modelsareusedsothattemporalcomponentscanbeintroducedandaccountedfor
in the exposure-outcome relationship. Typically, such data represent a sequence of
observations at successive times and spaced at uniform time intervals. An intrin-
sic statistical issue in the collection of time series data (lagged data) is having the
appropriate amount of sequenced information collected for each subject. More
speciﬁcally, the value of some of the the variables of interest may not be observ-
able for all study participants. For example, a variable may be observed for 80%
of the study, but unobserved for the other 20%. This presents a unique problem
when dealing with pollution exposure data and potentially any longitudinal study
where missing data are involved. A mechanism/procedure must accurately and
efﬁciently estimate the missing information or risk conducting an analysis with
insufﬁcient data. This missing data issue could be more easily illustrated through
the following example:
48At the initial start date of a study, there are no indoor exposure measurements
for time lags previous to the start date. As a result, the data are incomplete and
those rows of data must be deleted in order to proceed further with an analysis.
For example, Table 2.1 shows sample exposure data for 7 lagged days. In order to
calculate the 4-day moving average the data are insufﬁcient. In the sample data, it
can be readily seen that each subject was followed for 7 days but the 4-day moving
average can only be calculated for the last 4 measurements of each ID because the
rows with NA’s must be deleted as seen in Table 2.2. Subsequently, to conduct
the analysis investigators must work from a reduced data set like the one seen in
Table 2.3. Given that each subject should have a ﬁxed number of measurements
taken at successive time points, our proposed regression calibration method seeks
to impute the missing moving averages using the existing exposure information.
We would like to condition on the current observed information to ﬁnd estimates
for themissing 4-dayaverages asseen intable four. This wouldallow investigators
to utilize all of their data more efﬁciently.
Start Date
ID xi;0 xi;1 xi;2 xi;3 xi;4 xi;5 xi;6
1 3.6 4.7 5.2 3.8 4.1 3.9 5.6
2 3.5 5.6 4.3 4.7 3.2 2.9 6.4
3 2.6 6.5 3.4 5.6 2.3 3.8 5.5
4 3.7 5.2 4.5 5.2 3.6 4.8 6.5
Table 2.1: SAMPLE OBSERVED DATA - This table represents the observed exposure data over a
7 day period.
The data that motivates the proposed research comes from the analyses conducted
through the Electric Power Research Institute through the Harvard School of Pub-
lic Health on the effects of indoor and outdoor air pollution (particulate matter,
black carbon, carbon monoxide, ozone, nitrogen dioxide, and sulfur dioxide) on
children with respiratory illnesses. Investigators have conducted a number of re-
49Start Date
ID X
(4)
i;0 X
(4)
i;1 X
(4)
i;2 X
(4)
i;3 X
(4)
i;4 X
(4)
i;5 X
(4)
i;6
1 NA NA NA 4.325 4.45 4.25 4.35
2 NA NA NA 4.525 4.45 3.775 4.3
3 NA NA NA 4.525 4.45 3.775 4.3
4 NA NA NA 4.65 4.625 4.525 5.025
Table 2.2: SAMPLE MOVING AVERAGE DATA - This table represents the observed exposure
data for a 4-day moving average by id.
ID X
(4)
i;3 X
(4)
i;4 X
(4)
i;5 X
(4)
i;6
1 4.325 4.45 4.25 4.35
2 4.525 4.45 3.775 4.3
3 4.525 4.45 3.775 4.3
4 4.65 4.625 4.525 5.025
Table 2.3: SAMPLE REDUCED MOVING AVERAGE DATA - This table represents the observed
exposure data for a 4-day moving average by id where the missing values were deleted.
gression analyses using moving averages of exposure and these outcomes. Pol-
lutants were measured from two central monitoring sites in New York City, NY
while the indoor exposures were measured using indoor sampling apparatus. The
outcomes of interests were onset of asthma, eczema, hay fever, and pulmonary
function.
This paper is organized as follows: Section 2.3 describes in detail the design and
data from a study evaluating the effects of particulate air pollution on outcome.
Section 2.4 presents the exposure/error model, subsequent imputation algorithms,
and model mis-speciﬁcation. Section 2.5 presents a simulation study to examine
the effectiveness of the imputation methods compared to existing approaches and
tests the robustness of the regression calibration and Section 2.6 demonstrates an
application of the regression calibration methods to analyze the afore mentioned
study from Exposure, Epidemiology, and Risk Program. Finally in Section 2.7 we
discuss our ﬁndings along with its implications.
50ID X
(4)
i;0 X
(4)
i;1 X
(4)
i;2 X
(4)
i;3 X
(4)
i;4 X
(4)
i;5 X
(4)
i;6
1 X(4)jX(1) X(4)jX(2) X(4)jX(3) 4.325 4.45 4.25 4.35
2 X(4)jX(1) X(4)jX(2) X(4)jX(3) 4.525 4.45 3.775 4.3
3 X(4)jX(1) X(4)jX(2) X(4)jX(3) 4.525 4.45 3.775 4.3
4 X(4)jX(1) X(4)jX(2) X(4)jX(3) 4.65 4.625 4.525 5.025
Table 2.4: MOVING AVERAGE IMPUTATION IDEA - This table represents the observed expo-
sure data for a 4-day moving average by id.
2.3 DATA
Subjects were recruited from 6 different mediums; The Pediatric Emergency De-
partment at MSSM, Chest Clinic at MSSM, Asthma Support Group at MSSM,
Health Fairs, Referral from outside sources, and Advertisements. Children be-
tween the ages of 6 and 14 with moderate to severe asthma as deﬁned by NIH
criteria. Each subject had to reside North of 96th Street in Manhattan and South of
Cross Bronx Expressway in the Bronx and sleep in the same place at least 5 nights
a week. Children with active disease other than asthma requiring daily medica-
tions and those with mental retardation were excluded. Further exclusions were
smoking in the home and family planning to move from current home within the
next six months.
2.4 MOVING AVERAGE IMPUTATION
To begin, let Xit represent the value of a particular air pollutant and X
(n)
i;t is the
n-day moving average for subject i at time t. Let Yit be the value of the outcome
of interest for subject i at time t. We recognize that pollution measures taken at
close intervals in time should be correlated and our estimate of the missing values
should take this into consideration. Allow each subject to have covariate expo-
51sure measurements for the current day and 6 previous days yielding a total of 7
measurements for each subject. In total one subject may have between 1 and 6
missing values (per visit if needed). For instance, if there is one missing value for
themovingaverage, thenwecanusethe6daymovingaveragefromtheremaining
observed values to estimate the 7 day moving average value of air pollution. In the
data, it can be readily seen that each subject was followed for 14(2 weeks) days but
the full 7-day moving average can only be calculated for the last 8 measurements
of each ID as in the example in section 2.2. To conduct the analysis without operat-
ing from a reduced data set that deletes unobserved moving averages, a regression
calibration can be performed. Each 7-day moving average will be estimated condi-
tional on incomplete but observed exposure information. Therefore each X(7)jX(m)
is estimated conditional on the m-day moving average where m < 7. Table 2.5
can give a theoretical illustration of the values being estimated. We assume the
following mean model and error:
ID X
(7)
i;0 ... X
(7)
i;6 X
(7)
i;7 X
(7)
i;8 ... X
(7)
i;14
1 X(7)jX(1) ... X(7)jX(6) x
(7)
1;7 x
(7)
1;8 ... x
(7)
1;14
2 X(7)jX(1) ... X(7)jX(6) x
(7)
2;7 x
(7)
2;8 ... x
(7)
2;14
3 X(7)jX(1) ... X(7)jX(6) x
(7)
3;7 x
(7)
3;8 ... x
(7)
3;14
4 X(7)jX(1) ... X(7)jX(6) x
(7)
4;7 x
(7)
4;8 ... x
(7)
4;14
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
30 X(7)jX(1) ... X(7)jX(6) x
(7)
30;7 x
(7)
30;8 ... x
(7)
30;14
Table 2.5: MOVING AVERAGE IMPUTATION IDEA - This table represents the observed expo-
sure data for a 7-day moving average by id.
2.4.1 Simple Exposure Model Including of Covariates
The simple exposure model is as follows:
52Xi = Wi + i (2.1)
Where Xi represents a vector of exposure observations for subject i. Each of its
components are of the form Xit for subject i at time t. Wi is a vector of possible
confounders that inﬂuence the level exposure and it components are of the form
Wit for the ith subject at time t. For 1  t  T and 1  i  N. i  N(0;) so
that Xi  N(Wi;) . Also assume that the errors follow the AR(1) correlation
structure where (n), and (n) are the correlation matrix and variance-covariance
matrix for the n-day moving average respectively.

(7) =
2
6 6 6 6 6
6 6 6 6 6
4
1  2 ::: 6
 1  ::: 5
2  1 ::: 4
. . .
. . .
. . . ... . . .
6 5 4 ::: 1
3
7 7 7 7 7
7 7 7 7 7
5
;
In general, we have the correlation and covariance relation formula that can be
rearranged to compute all of the components of the variance covariance matrix for
the errors.
 =
cov(x;y)
xy
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2.4.2 Distribution of the Moving Average
E [XitjW1it;:::;Wnit] = 0 + 1W1it +  + nWnit
Let S
(n)
it represent the sum of the pollutant measures for the ith subject at time t.
Therefore we have M
(n)
it represents the n-day moving average for the ith subject at
time t. The respective distributions are as follows:
S
(n)
it = Xi1 + Xi2 + Xi3  + Xin
M
(n)
it =
S
(n)
it
n
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We assume the following AR(1) correlation structure as before. Below is the distri-
bution of the moving averages.
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Where L and LT are vectors of scalar values reﬂecting the moving average. Since
we know that M(7) and M(6) are both normally distributed, then the conditional
distribution is also normal. To formalize this notion we want the conditional dis-
tribution of M(7)jM(6). Given the following general formulas for the conditional
normal distribution:
ijj = i + ij
 1
jj (Xj   j) (2.2)
ijj = jj   
T
ij
 1
ii ij (2.3)
In particular we have the following equations related to our example in matrix
notation:
M(7)jM(6) = [7] + [7;6]
 1
[6](M
(6)   [6]
M(7)jM(6) = [6]   
T
[7;6]
 1
[7][7;6]
56As scalars:
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Now, we must solve for each of the missing values [7], [7;6], 2
[6], and 2
[7] using the
following equations.
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For the covariance between the 7-day and 6-day moving average, we have the
following derivation:
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The rest of the needed values can be derived in the same fashion and their values
are given below:
58[7] = Wi
[6] = Wi
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Wi
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Wi
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Wi
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Wi
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Wi
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59Conditional Distribution of the Moving Average
So ﬁnally, we know that the conditional distributions for the 7-day moving av-
erage are given below where M(n)jM(m) = W (n) +
[n;m]
2
[m]
(M(m)   W (n)) and
M(n)jM(m) = 2
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Given the original mean model, the AR(1) correlation structure assumption, and
the resulting conditional distribution we can estimate the missing moving aver-
age values from table 2.5 in section 2.3. By running a regression model, estimates
for ^ , ^ , and ^ 2 would be obtained and those resulting values can be used to im-
pute/recreate missing estimates given the observed data. Consequently, a regres-
sion analysis can be conducted on the resulting data.
2.4.3 Nonparametric Moving Average Imputation
Initially, we assumed an exposure model, correlation of the errors, and the corre-
sponding exposure distribution. The resulting mean functions were linear in form
where each 7-day moving average of exposure was a linear function of the previ-
60ous days values. For example take
M(n)jM(m) = W
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For Imputation method 2, we choose to assume an unspeciﬁed linear relationship
between the 7-day moving averages and the previous days. This relationship is
deﬁned by the estimates 0 and 1.
M
(7;r)
it = 06 + 16M
(6;r)
it
M
(7;r)
it = 05 + 15M
(5;r)
it
M
(7;r)
it = 04 + 14M
(4;r)
it
M
(7;r)
it = 03 + 13M
(3;r)
it
M
(7;r)
it = 02 + 12M
(2;r)
it
M
(7;r)
it = 01 + 11M
(1;r)
it
Where M
(nr)
it is the moving average from the reduced data set. Once, this simple
regression is conducted, the estimates of ^ 0 and ^ 1 can be extracted and used to
them to generate values for the missing moving averages.
61M(7)jM(6) = M
(7)
i6 = ^ 06 + ^ 16M
(6)
i6
M(7)jM(5) = M
(7)
i5 = ^ 05 + ^ 15M
(5)
i5
M(7)jM(4) = M
(7)
i4 = ^ 04 + ^ 14M
(4)
i4
M(7)jM(3) = M
(7)
i3 = ^ 03 + ^ 13M
(3)
i3
M(7)jM(2) = M
(7)
i2 = ^ 02 + ^ 12M
(2)
i2
M(7)jM(1) = M
(7)
i1 = ^ 01 + ^ 11M
(1)
i1
The values obtained could replace any absent moving averages that had been
deleted in the reduced data. The results are explained in the next section through
the use of a comprehensive table.
2.4.4 Data Reduction and Daily Imputation
Many investigators remove those subjects with missing exposure/covariate obser-
vations. This will represent the ”reduced method”. Imputation method #3 repre-
sents the conventional means of imputing data in panel studies. Rather than using
the the moving average to reproduce the missing moving averages, this calibration
strategy seeks to impute each of the individual missing observations and calculate
the resulting moving averages to conduct the analyses. This is accomplished by
regressing the original outcome data on the original exposure data and using the
predicted values to impute each missing value. Once the missing values are com-
puted and the unobserved covariates are then replaced by their predicted values
from the calibration model, merged with the existing data set, and regression anal-
62ysis can be undertaken. Finally, the standard errors are adjusted to account for the
estimation of the unknown covariates. The typical approach is to calculate stan-
dard errors using bootstrap or sandwich methods, but asymptotic standard errors
are available as well.
^ Xi6 = ^ 0 + ^ 1W1i6
^ Xi5 = ^ 0 + ^ 1W1i5
^ Xi4 = ^ 0 + ^ 1W1i4
^ Xi3 = ^ 0 + ^ 1W1i3
^ Xi2 = ^ 0 + ^ 1W1i2
^ Xi1 = ^ 0 + ^ 1W1i1
Then we substitute ^ Xi1;:::; ^ Xi6 in for the missing daily values and subsequently
construct the moving averages.
2.4.5 Regression Calibration
Each one of the afore mentioned methods represents a form of regression calibra-
tion. In a conventional analyses, investigators would like to detail the relationship
between a particular response Y and its predictors. For simplicity we will dis-
tinguish between two different types of predictors X and Z. Z represents those
predictors that can be measured without error and X represents those that cannot
be observed for all subjects. We may be able to observe a variable W which is
related to X. Since the parameters of the model relating Y to (Z,X) cannot be ﬁt-
63ted accurately due to the unobservable X, hence the surrogate relationship of Y on
(Z,W) must be modeled. The structure of the error model relating X to W is the
basis of regression calibration. Once the error model has been developed, the dis-
tribution and conditional distributions of X can be derived. Lastly, we replace the
unobserved exposures X by its mean function m(Z;W;) and run the appropriate
standard regression analysis(Carroll, 1995). The following simulation will help to
illustrate these ideas.
2.5 SIMULATION STUDY
We conducted a simulation study to examine the effectiveness of the imputation
method in estimating missing values in time series data. Upon estimation of the
missing values, the next goal was to produce a parameter estimate for the effect of
exposure on outcome. The simulations were to be conducted in three phases; 1a)
We created three data sets where the ﬁrst will be a reduced data set where rows
of data were deleted due to the missing observations. 1b) The second data set
consisted of a full data set where the previously missing values were imputed. 1c)
The last data set was simulating true data where no missing values existed or were
imputed. Our next step was to run mixed effects models on each of these data
sets and compare the effect estimates with the true given values. The intended
outcomes, the moving averages, and the initial coefﬁcients needed to be simulated
in order to test consistency. We began by simulating exposure data with 30 unique
subjects and 20 lagged (24 hour) observations for each.
642.5.1 Simulating The Moving Average Data
We assumed 30 unique ”ID”(subject) each had 20 measurements (T=20) taken at
consecutive days. The assumed exposure model:
Xit = 0 + 1W1it + it;
where Xit is the exposure for subject i at time t. W1it represents simulated, ambient
pollutant exposure for weekday and weekends for subject i at time t. For example,
Wit represent ambient pollution on the weekday(WD) and weekend(WE).
W1it 
(
N(1;w2
1) if WD
N(2;w2
1) if WE
;
1 = 1, 2 = 0, and w2
1;w2
2 = 1. The errors were normally distributed
it  N(x;x). There were 3 error correlation structures assumed for simula-
tions: AR(1), AR(2), and ARMA(1;1). To simulate the daily exposure data we
used the following distribution: X  N(x;x). We assumed,
x =
2
6 6 6 6 6 6
6 6 6 6
4
2 2 22 ::: 220
2 2 2 ::: 219
22 2 2 ::: 218
. . .
. . .
. . . ... . . .
220 219 218 ::: 2
3
7 7 7 7 7 7
7 7 7 7
5
;
65where  = 0:4;0:8, 2 = 0:3;0:9;1:5, and x
(n) = 0 + 1W
(n)
1it . The initial value of
0 was 0 and 1 was 1. This structure was used to reﬂect the fact that exposure
measurements taken at closer intervals are more highly correlated. These initial
values were taken from averages in the real data.
2.5.2 Simulating Outcome
The linear model of interest could be written in the following way:
Yit = 0 + 1M
(7)
it + bi + it
where M
(7)
it is the moving average for the ith subject at time t.
 bi  N(0;2
b) are the random coefﬁcients due to ith subject.
 it  N(0;2
) is the error term for the ith subject and time t.
 Initial values were chosen for 0 = 0 and 1 = 1
 Yit was simulated from the following distribution:
YitjM
(7)
it ;0;1  N(0 + 1M
(7)
it ;
2
y1)
where 2
yit = 2
bi + 2
it.
The simulations were to be conducted in three phases where 5 data sets of ex-
posure were created. First, a reduced data set where rows of data were deleted
due to the missing observations. In this case, there would be 30 unique subjects
66at 7 time points (210 observations) remaining. This clearly decreases the amount
of exposure data available for modeling. Second, 3 imputed data sets where the
previously missing moving averages/values were imputed where the parametric
moving average imputation (PMA), the nonparametric moving average imputa-
tion (NPMA), and the daily value imputation (DIMA) are conducted. This will
amount to 30 unique subjects at 14 time points (420 observations) consisting of 180
imputed values for the 7-day moving average and 120 imputed values for the 4-
day moving average. Lastly, we simulated true data ”gold standard/truth” where
no missing values existed or were imputed. This will be represented by a fully
simulated data set where there are no missing values and the moving averages
can be calculated for each observation. This corresponds to 30 unique subjects at
14 time points (420 observations). In total, this amounts to each subject having 14
days of available exposure information to be used in the modeling process.
Our next step was to run mixed effects models on each of these data sets and com-
pare the effect estimates with the true given values. The mixed effects models
conducted:
Yit = 0 + 1M
(7;reduced)
it + bi + it
Yit = 0 + 1M
(7;PMA)
it + bi + it
Yit = 0 + 1M
(7;NPMA)
it + bi + it
Yit = 0 + 1M
(7;DIMA)
it + bi + it
Yit = 0 + 1M
(7;truth)
it + bi + it
These models were simulated for 200 iterations and no covariates were included.
67The results are explained in section 4.5 through the use of a comprehensive table.
2.5.3 Relaxing the AR(1) Assumption
The conditional distributions are accurate under the given assumptions, but when
the AR(1) covariance structure is relaxed new derivations must be developed. The
AR(1) or ARIMA(1,0,0) covariance structure is a simplest case of ARIMA models.
ARIMA models are, in theory, they are the most general class of models for fore-
casting time series. It is of interest to determine whether the three afore mentioned
methods of imputation are robust when dealing with new correlation structures
and hence model mis-speciﬁcation. In order to investigate this issue, alternative
correlation structures for simulating exposure data were constructed. The correla-
tion structures of interest were AR(2) and ARMA(1,1). Data was simulated from
these two distributions respectively and subsequently imputation methods were
performed and compared.
Simulating ARMA(1,1) Exposure Data
Suppose that the errors followed a different correlation pattern had the following
ARIMA(1,0,1) or ARMA(1,1) covariance structure. In order to simulate the expo-
sure data we ﬁrst need to derive the variance covariance matrix. This was achieved
using the general equations for producing ARMA(p;q) errors in closed form by Jan
van der Leeuw where p are the autoregressive terms and q are the moving average
terms. Assume p = 1 and q = 1 for ARMA(1,1).
68V = [NM][  P T  P    Q  QT]
 1[NM]
T
where  P;  Q,M,N are well-deﬁned toeplitz matrices of the following form:
 P[2121] =
2
6
4
 P1 0
 P2  P3
3
7
5 =
2
6 6 6 6
6 6 6 6 6 6
6 6 6 6 6 6
6 6 6 6 6
4
1 0 0 ::: 0
1 1 0 ::: 0
0 1 1 ::: 0
0 0 1 ::: 0
0 0 0 ::: 0
. . .
. . .
. . . ... . . .
0 0 0 ::: 1
3
7 7 7 7
7 7 7 7 7 7
7 7 7 7 7 7
7 7 7 7 7
5
;
 Q[211] =
2
6
4
 Q1
0
3
7
5 =
2
6 6
6 6 6 6 6 6
6 6 6 6 6 6
6 6 6
4
1
0
0
0
0
. . .
0
3
7 7 7
7 7 7 7 7 7
7 7 7 7 7
7 7 7
5
;
69 M[2020] =
2
6
4
 M1 0
 M2  M3
3
7
5 =
2
6 6
6 6 6 6 6 6
6 6 6 6 6
6 6 6 6 6 6
6 6
4
1 0 0 ::: 0
1 1 0 ::: 0
0 1 1 ::: 0
0 0 1 ::: 0
0 0 0 ::: 0
. . .
. . .
. . . ... . . .
0 0 0 ::: 1
3
7 7
7 7 7 7 7 7
7 7 7 7 7
7 7 7 7 7 7
7 7
5
;
 N[201] =
2
6
4
 N1
0
3
7
5 =
2
6 6 6 6 6 6
6 6 6 6 6
6 6 6 6 6 6
4
1
0
0
0
0
. . .
0
3
7 7 7 7 7
7 7 7 7 7 7
7 7 7 7 7 7
5
;
We deﬁne P to be a (square) T  T lower band matrix where T (T=20) represents
the total number of days being simulated. Q is T  p and is partitioned into an
upper p  p part and a lower (T   p)  p part, which consists of only zeros. M and
N have the same structure as P and Q with ri replaced by  and p replaced by q.  P
is the same as P but the dimensions are (T + p)  (T + p) while  Q has dimensions
(T +p)p. Performing these matrix calculations result in the correlation matrix for
ARMA(p = 1;q = 1) errors [van der Leeuw,1994]. Initial values for 1 and 1 can be
chosen according to previous analyses or subject speciﬁc estimates. The ﬁnal form
of the ARMA(1,1) correlation structure is X below.
70X =
2
6
6 6 6 6 6 6
6 6 6
4
1  1 ::: 18
 1  ::: 17
1  1 ::: 16
. . .
. . .
. . . ... . . .
18 17 16 ::: 1
3
7 7 7 7 7 7
7 7 7 7
5
;
The corresponding covariance matrix will have the following form:
(X)  MV N
0
B B B B
B B B B B
B
@
0;(X) =
2
6 6 6 6
6 6 6 6 6
6
4
2 2 21 ::: 218
2 2 2 ::: 217
21 2 2 ::: 216
. . .
. . .
. . . ... . . .
218 217 216 ::: 2
3
7 7 7 7
7 7 7 7 7 7
5
1
C C C C
C C C C C C
A
;
To simulate the daily exposure data we used the following distribution: X 
N(x;xAR(2)). Now that the exposure data has been simulated the outcome data
can be simulated in the same fashion as ”Simulating Outcome”.
Simulating AR(2) Exposure Data
Assume p = 2 for the autoregressive coefﬁcient. For the ARIMA(p,0,0) or AR(p)
cases the covariance structure equations reduce to the following formula.
V = [P
TP   QQ
T]
 1
71where P,Q are well-deﬁned toeplitz matrices as before but are of different dimen-
sions of the following form:
P[2020] =
2
6
4
P1 0
P2 P3
3
7
5 =
2
6 6 6 6 6
6 6 6 6 6 6
6 6 6 6 6 6
6 6 6 6
4
1 0 0 ::: 0
1 1 0 ::: 0
2 1 1 ::: 0
0 2 1 ::: 0
0 0 2 ::: 0
. . .
. . .
. . . ... . . .
0 0 0 ::: 1
3
7 7 7 7 7
7 7 7 7 7 7
7 7 7 7 7 7
7 7 7 7
5
;
Q[202] =
2
6
4
Q1
0
3
7
5 =
2
6 6 6
6 6 6 6 6 6
6 6 6 6 6 6
6 6
4
2 1
0 2
0 0
0 0
0 0
. . .
. . .
0 0
3
7 7 7 7
7 7 7 7 7
7 7 7 7 7 7
7 7
5
;
The variance covariance matrix for AR(2) does not have a discernable pattern like
the others therefore the elements of the correlation structure will be left unspeci-
72ﬁed.

(7)  MV N
0
B B B B B B
B B B B B B
B B
@
0;
(7) =
2
6 6 6 6 6 6
6 6 6 6 6 6
6 6
4
a11 a12 a13 ::: a17
a21 a22 a23 ::: a27
a31 a32 a33 ::: a37
. . .
. . .
. . . ... . . .
a71 a72 a73 ::: a77
3
7 7 7 7 7 7
7 7 7 7 7 7
7 7
5
1
C C C C C C
C C C C C C
C C
A
;
Cov(M
(n);M
(m)) =
1
nm
"
7 X
t=n m
V (Xit) + 2[
7 X
t=n m
7 X
t0=n m
Cov(Xit;Xit0)] +
7 X
t0=n m
Cov(Xi1;Xit0)
#
where n > m. So for the covariance between M(7) and M(6) we would have:
Cov(M
(7);M
(6)) =
1
42
"
7 X
t=2
V (Xit) + 2[
7 X
t=2
7 X
t0=2
Cov(Xit;Xit0)] +
7 X
t0=2
Cov(Xi1;Xit0)
#
=
1
42
"
7 X
j=1
ajj + 2[
7 X 7 X
j>k
ajk] +
7 X
j=2
aj1
#
2.5.4 Simulation Results
We conducted a simulation study to examine the effectiveness of three regression
calibration methods of estimation for missing data. We would also like to perform
a direct comparison of the point estimates between each of the relevant methods
through calculation of the mean squared errors. The initial values for the corre-
73lation coefﬁcients and variances must be simulated under varying assumptions
in order to get a complete picture of the regression calibration effectiveness. We
began with 30 unique subjects with 20 observations taken on 20 consecutive days.
The20laggedtime-pointswerecreatedtosimulate3weeksofexposuredata. Table
6 represents the initial values chosen for the simulation study. For each correlation
structure, AR(1), AR(2), and ARMA(1,1), the correlation coefﬁcient, moving aver-
age coefﬁcient, and variance were needed. Each scenario produced 5 data sets and
linear mixed models were run all assuming AR(1) error structures. We adjusted
the resulting standard errors to account for the estimation of  by using the boot-
strap method. Both 7-day and 4-day moving averages were conducted over the
20 day period. Under the 7-day moving average 6 conditional exposure measure-
ments must estimated per subject while in 4-day moving averages only 3 must be
estimated per subject.
AR(1) Simulation Results
We found that when the model was properly speciﬁed meaning that the simulated
data was in accord with linear mixed model, all the point estimates among all data
sets are very close to the true values of 0 = 0 and 1 = 1. This shows that there was
little bias found in the well speciﬁed cases although there were clear differences in
efﬁciency. Model efﬁciency was determined by the mean squared error. Using the
ﬁrst regression calibration method(PMA) yielded the lowest MSE as can be seen in
Table 2.7. The models that used the reduced had the highest MSE values and hence
the lowest efﬁciency because the standard errors and standard deviations were the
highest. Using PMA increased efﬁciency by approximately 25%   40% over the
reduced method depending on the initial values for 2. Further, PMA was more
74efﬁcient than the other two calibration methods (NPMA and DIMA) but by smaller
margins. PMA tends to be around 5%   10% more efﬁcient than the other NPMA
methods when the model is properly speciﬁed. For example, in the simulation
scenario for AR(1) where = :8 and 2 = :9 for the 4-day moving average we have
the following output which can be seen in Table 2.7. All of the 1 point estimates
are quite close to the simulated starting value of 1. But looking at the MSE of
^ 1;reduced = 0.019 while for ^ 1;PMA = 0.009. This reﬂects more than a50% decrease in
the MSE which means the PMA is at an advantage above deleting incomplete data.
When comparing PMA to conventional regression calibration method 3 (DIMA),
there is no reduction in MSE when moving from ^ 1;reduced = 0.009 to ^ 1;DIMA = 0.009
for 2 = :9 but for 2 = 1:5 and 2 = 2:0 there are small gains in efﬁciency. These
patterns are consistent throughout all of the proposed AR(1) cases.
AR(2) and ARMA(1,1) Simulation Results
We found that when the model was mis-speciﬁed, there were new patterns re-
vealed. There were two cases of mis-speciﬁcation that were investigated. The ﬁrst
was simulating data with an AR(2) error correlation structure but modeled with
an AR(1). The second was simulating data with an ARMA(1,1) error correlation
structure but modeled with and AR(1). Each of the these cases are different repre-
sentations of the larger class of ARIMA models with small parameter shifts.
PMA and NPMA methods performed with very little bias in most cases while the
conventional methodology used in DIMA experienced high levels of bias. Small
deviations from AR(1) were examined such as AR(2) with 1 = :8,2 = :1 and
ARMA(1,1) with1 = :8,2 = :2 each of which were done with both 4 and 7
day moving averages. These cases reﬂect marginal departures from AR(1) error
75structure but elicit large responses in bias of the ^ 1 estimates. Table 7 shows that
the conventional DIMA for AR(2) has the following values for AR(2): ^ 1;DIMA =
0.946(0.053), 0.943(0.022), 0.924(0.020), 0.927(0.015) for 2 = :3;:9;1:5;2:0 respec-
tively. Each point estimate underestimates the simulated value of 1 by greater
than 5%. This trend is echoed in the ARMA(1,1) case for DIMA. The values for
ARMA(1;1) are as follows: ^ 1;DIMA = 0.9478(0.0495), 0.9359(0.0215), 0.9291(0.0180),
0.9347(0.0161)for2 = :3;:9;1:5;2:0respectivelywhichalsounderestimatethesim-
ulated value of 1 by > 5%. On the other hand, the PMA and NPMA methods show
very low bias in the point estimates as they are all very close to 1. The MSE’s are
also lower for PMA and NPMA methods than for the DIMA method for increas-
ing variability. For example, when 2 = 2:0 the MSEAR(2)(DIMA) = 0:015 while
MSEAR(2)(PMA) = 0:010. Alternativelyfor2 = :3theMSEAR(2)(DIMA) = 0:053
while the MSEAR(2)(PMA) = 0:055.
Large deviations from AR(1) were explored as well AR(2) with 1 = :8,2 = :5
and ARMA(1,1), 1 = :8,2 = :5 and ﬁndings are similar. These cases reﬂect larger
departures from AR(1) error structure but elicit smaller responses in bias. Table
8 shows that the conventional DIMA method for AR(2) has the following values
for AR(2): ^ 1;DIMA = 0.992 (0.046), 0.969(0.013), 0.964(0.014), 0.964(0.011) for 2 =
:9;1:5;2:0 respectively. Each point estimate underestimates the simulated value of
1 by greater than 3% accept when 2 = 2. This trend is echoed in the ARMA(1,1)
case for the DIMA method. The values for ARMA(1;1) are as follows: ^ 1;DIMA =
0.961(0.045),0.973(0.0190), 0.964(0.014), 0.972(0.009)for2 = :9;1:5;2:0respectively
which also underestimate the simulated value of 1 by > 5%. On the other hand
PMA and NPMA methods show very low bias in the point estimates as they are
all very close to 1.
762.6 DISCUSSION
These results show that both the parametric and nonparametric imputations us-
ing moving averages yield more robust health effects estimates than the reduced
and daily value imputation methods. This is the trend in all of the simulations
regardless of the correlation structure chosen. Further, the simulations show that
the daily value imputation methods (DIMA) experience higher levels of bias when
the models are mis-speciﬁed. This means that in the circumstance where the cor-
relations structures are unknown and are very different than AR(1), the DIMA ap-
proach may have clear issues with accuracy. On the other hand, the moving aver-
age imputation methods (PMA and NPMA) maintain high accuracy and efﬁciency
in comparison with the gold standard (truth). Our methods were conducted on 7-
day moving averages which required 6 imputed moving averages to be estimated
while the 4-day moving averages required 3 moving average estimates. The same
patterns were maintained irrespective of the length of the imputation. We also at-
tempted the bootstrap method to calculate the standard errors but due to the small
sample sizes in each panel, the values were higher than normal.
The reason for the differences in both bias an efﬁciency are a result of the PMA and
NPMA approaches consideration of speciﬁc correlation structures of the exposure
measurements. The DIMA imputation methods assume a linear relationship be-
tween the exposure measurements at different times and use estimated predicted
values to estimate missing exposure data. On the other hand, the PMA and NPMA
methods use correlations that allow the methods to draw upon pollution informa-
tion from previous days in order to estimate the missing moving averages. With
the inclusion of the assumed error structures for the exposures, the estimates from
the health effects model are closer to the best linear unbiased predictor (BLUP).
772.7 APPENDIX
 Estimate(MSE), MA4 Continuous Covariate
AR(1),  = :8 2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(1),  = :4 2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :4,2 = :2 2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :8,2 = :1 2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :8,2 = :4 2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :8,2 = :5 2 = :3 2 = :9 2 = 1:5 2 = 2:0
ARMA(1,1), 1 = :4,2 = :2 2 = :3 2 = :9 2 = 1:5 2 = 2:0
ARMA(1,1), 1 = :8,2 = :2 2 = :3 2 = :9 2 = 1:5 2 = 2:0
ARMA(1,1), 1 = :8,2 = :5 2 = :3 2 = :9 2 = 1:5 2 = 2:0
Table 2.6: 30 Unique IDs - This table represents the initial values chosen for the simulation study.
For each correlation structure, AR(1), AR(2), and ARMA(1,1), the correlation coefﬁcient, moving
average coefﬁcient, and variance were needed. Each scenario produced 5 data sets.
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1 Estimate(MSE), MA4 Continuous Covariate
2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(1),  = :8
^ 1;reduced 0.966 (0.051) 0.986 (0.019) 0.998 (0.017) 0.986 (0.008)
^ 1;PMA 0.992 (0.023) 0.997 (0.009) 1.009 (0.011) 0.995 (0.004)
^ 1;NPMA 0.996 (0.025) 0.996 (0.009) 1.008 (0.011) 0.994 (0.004)
^ 1;DIMA 1.005 ( 0.025) 1.006 (0.009) 1.019 (0.015) 1.006 (0.005)
^ 1;true 0.988 (0.020) 0.992 (0.008) 1.006 (0.006) 0.996 (0.004)
AR(2), 1 = :8,2 = :1
^ 1;reduced 0.986 (0.099) 1.026 (0.040) 0.992 (0.029) 1.001 (0.018)
^ 1;PMA 0.999 (0.055) 1.019 (0.023) 0.993 (0.015) 1.003 (0.010)
^ 1;NPMA 1.021 (0.058) 1.030 (0.023) 1.001 (0.017) 1.007 ( 0.011)
^ 1;DIMA 0.946 (0.053) 0.943 (0.022) 0.924 (0.020) 0.927 (0.015)
^ 1;true 1.005 (0.049) 1.023 (0.020) 0.994 (0.012 ) 1.0030 (0.089)
ARMA(1,1), 1 = :8,2 = :2
^ 1;reduced 0.972 (0.099) 0.997 (0.036) 1.009 (0.025) 1.020 (0.022)
^ 1;PMA 0.993 (0.049) 1.001 (0.020) 1.003 (0.014) 1.010 (0.014)
^ 1;NPMA 1.013 (0.056) 1.007 (0.021) 1.008 (0.015) 1.015 (0.014)
^ 1;DIMA 0.948 (0.050) 0.936 (0.022) 0.929 (0.018) 0.935 (0.016)
^ 1;true 0.998 (0.046) 1.000 (0.017) 1.006 (0.012) 1.011 (0.012)
Table 2.7: Small Deviations from AR(1) for 4-day Moving Average - This table represents the pa-
rameter estimates for a 4-day moving average from 5 separate linear mixed model using simulated
data from the reduced, imputed, and true data sets. Linear mixed mean models were conducted
for 200 iterations. The subsequent estimates were aggregated into means with accompanying MSE.
Each model included one continuous covariate for weekend. All of the simulation standard errors
are < 0.019.
1 Estimate(MSE), MA4 Continuous Covariate
2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :8,2 = :5
^ 1;reduced 1.004 (0.072) 1.021 (0.021) 1.001 (0.022) 0.992 (0.018)
^ 1;PMA 1.002 (0.047) 1.006 (0.013) 0.989 (0.014) 0.999 (0.010)
^ 1;NPMA 1.032 (0.051) 1.024 (0.014) 0.997 ( 0.013) 1.016 (0.011)
^ 1;DIMA 0.992 (0.046) 0.969 (0.013) 0.964 (0.014) 0.964 (0.011)
^ 1;true 1.007 (0.040) 1.012 (0.017) 0.991 (0.011) 1.005 (0.009)
ARMA(1,1), 1 = :8,2 = :5
^ 1;reduced 0.939 (0.084) 1.001 (0.034) 1.001 (0.022) 0.998 (0.019)
^ 1;PMA 0.980 (0.046) 1.003 (0.019) 0.989 (0.014) 0.997 (0.009)
^ 1;NPMA 0.992 (0.050) 1.007 (0.020) 0.997 (0.013) 0.999 (0.009)
^ 1;DIMA 0.961 (0.045) 0.973 (0.0190) 0.964 (0.014) 0.972 (0.009)
^ 1;true 0.980 (0.042) 1.006 ( 0.016) 0.991 (0.011) 0.991 (0.008)
Table 2.8: Large Deviations From AR(1) for 4-day Moving Average - This table represents the pa-
rameter estimates for a 4-day moving average from 5 separate linear mixed model using simulated
data from the reduced, imputed, and true data sets. Linear mixed mean models were conducted
for 200 iterations. The subsequent estimates were aggregated into means with accompanying MSE.
Each model included one continuous covariate for weekend. All of the simulation standard errors
are < 0.019.
791 Estimate(MSE), MA7 Continuous Covariate
2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(1),  = :8
^ 1;reduced 1.013 (0.082) 0.989 (0.030) 1.008 (0.011) 0.988 (0.013)
^ 1;PMA 1.015 (0.042) 0.997 (0.017) 1.020 (0.004) 1.016 (0.009)
^ 1;NPMA 0.986 (0.046) 0.987 (0.019) 1.011 (0.004) 1.006 (0.009)
^ 1;DIMA 1.016 (0.052) 0.989 (0.023) 1.004 (0.005) 1.007 ( 0.013)
^ 1;true 1.015 (0.030) 0.988 (0.010) 1.004 (0.004) 1.001 (0.005)
AR(2), 1 = :8,2 = :1
^ 1;reduced 1.015 (0.111) 1.026 (0.040) 1.015 (0.071) 0.998 (0.049)
^ 1;PMA 1.025 (0.070) 1.019 (0.023) 1.010 (0.041) 1.003 (0.033)
^ 1;NPMA 1.048 (0.084) 1.030 (0.023) 1.0289(0.0450) 1.0151(0.0336)
^ 1;DIMA 0.964 (0.064) 0.943 (0.022) 0.942 (0.039) 0.935 (0.035)
^ 1;true 1.021 (0.057) 1.023 (0.020) 0.996 (0.030) 0.997 (0.022)
ARMA(1,1), 1 = :8,2 = :2
^ 1;reduced 0.948 (0.260) 0.958 (0.095) 1.015 (0.051) 1.026 (0.035)
^ 1;PMA 0.978 (0.134) 0.989 (0.063) 1.024 (0.040) 1.037 (0.026)
^ 1;NPMA 0.995 (0.163) 0.996 (0.063) 1.028 (0.041) 1.037 (0.026)
^ 1;DIMA 0.946 (0.124) 0.945 (0.061) 0.973 (0.038) 0.984 (0.023)
^ 1;true 0.971 (0.109) 0.984 (0.046) 1.007 (0.023) 1.008 (0.018)
Table 2.9: Small Deviations From AR(1) for 7-day Moving Average - This table represents the pa-
rameter estimates for a 7-day moving average from 5 separate linear mixed model using simulated
data from the reduced, imputed, and true data sets. Linear mixed mean models were conducted
for 200 iterations. The subsequent estimates were aggregated into means with accompanying MSE.
Each model included one continuous covariate for weekend. All of the simulation standard errors
are < 0.036.
1 Estimate(MSE), MA7 Continuous Covariate
2 = :3 2 = :9 2 = 1:5 2 = 2:0
AR(2), 1 = :8,2 = :5
^ 1;reduced 1.027 (0.272) 0.985 (0.121) 1.017 (0.076) 0.994 (0.051)
^ 1;PMA 1.037 (0.168) 0.950 (0.089) 1.001 (0.047) 0.977 (0.031)
^ 1;NPMA 1.089 (0.232) 1.005 (0.097) 1.051 (0.059) 1.019 (0.034)
^ 1;DIMA 0.996 (0.156) 0.903 (0.089) 0.949 (0.045) 0.924 (0.034)
^ 1;true 1.058 (0.151) 0.968 (0.059) 1.022 (0.040) 0.995 (0.022)
ARMA(1,1), 1 = :8,2 = :5
^ 1;reduced 1.036 (0.214) 0.983 (0.074) 1.006 (0.050) 0.991 (0.037)
^ 1;PMA 1.051 (0.126) 0.998 (0.044) 1.010 (0.035) 0.999 (0.025)
^ 1;NPMA 1.051 (0.134) 0.999(0.047) 1.011(0.033) 0.999(0.026)
^ 1;DIMA 1.050 (0.119) 0.976(0.043) 0.986(0.034) 0.974(0.024)
^ 1;true 1.018 (0.099) 1.001(0.033) 0.996(0.025) 0.988(0.015)
Table 2.10: Large Deviations From AR(1) for 7-day Moving Average - This table represents the pa-
rameter estimates for a 7-day moving average from 5 separate linear mixed model using simulated
data from the reduced, imputed, and true data sets. Linear mixed mean models were conducted
for 200 iterations. The subsequent estimates were aggregated into means with accompanying MSE.
Each model included one continuous covariate for weekend. All of the simulation standard errors
are < 0.036.
80Health Effects of Multipollutant Mixtures: Testing
Properties of Source Apportionment and Two-Stage
Hierarchical Regression Methods
1Alfa I. Yansan´ e, 2;3Diane R. Gold, 1;4Paul J. Catalano,1 Brent A.
Coull
1Department of Biostatistics, Harvard School of Public Health
2Department of Environmental Health, Harvard School of Public
Health
3Department of Medicine, Brigham and Women’s
Hospital/Harvard Medical School and
4Department of Biostatistics, Dana-Farber Cancer Institute3.1 ABSTRACT
One of the core questions in environmental health and pollution research is to
identify the health effects associated with speciﬁc pollution sources and their con-
stituents. Therequirementsofsuchstudiesincludedeterminingairpollutionemis-
sions, ambient concentrations by pollution type and particle composition, and the
associated health impacts. Since most pollution studies are unable to directly ob-
serve the pollution contributions of speciﬁc sources, determining the source spe-
ciﬁc health risk can be difﬁcult. Conventional approaches such as, source appor-
tionment, principle components analysis, and two-stage hierarchical regression
have been widely used in the analysis of multipollutant mixtures. Little work has
been done to evaluate the appropriate use of each method and characterizing the
premier approach has not been resolved. The purpose of this article is to develop
a simulation study that compares the source apportionment and two-stage hierar-
chical regression methods by detailing the power and type 1 errors of the related
health affects.
823.2 INTRODUCTION
Exposure to air pollutants has been linked with adverse health outcomes, includ-
ing increased premature mortality and morbidity, respiratory and cardiovascular
disease, andincreasesinhospitaladmissions(Dockeryetal., 1993; Popeetal., 1999;
Brooks et al., 2004; Zanobetti et al., 2004). Recent studies have shown that these
outcomes differ according to speciﬁc pollutant mixtures, sources of pollution, and
particle composition. Given these concerns, recent studies have attempted to ex-
amine the risks associated with pollutant mixtures as a whole as opposed to single
pollutants. Analyses from Brook et al. 2009 shows that health effects can vary
by air pollution mixtures. Alternatively, single pollutant approaches do not ade-
quately estimate cumulative or joint effects of multiple pollutants. In addition to
exploration of pollutant mixtures, it is of interest to understand the relative toxicity
of individual pollutants to identify the toxic sources. These are important scientiﬁc
goals, but the methods used to accomplish these aims have not been carefully vet-
ted. Conventional strategies for analyzing such data include: 1) ﬁtting a full model
that contains a collection of individual pollutant concentrations; 2) using stepwise
model selection; and 3) conducting a number of separate models each containing a
single exposure. Each of these approaches do not provide satisfactory solutions to
the multiple, correlated exposure problem because of multiple testing issues and
the fact that they do not address pollution mixtures (Witte et al., 1996; Momoli et
al., 2009).
Two methods have primarily been used in the estimation of effects from multi-
ple correlation exposures. The ﬁrst approach is source apportionment. Most PM
health studies do not directly observe the contributions of the speciﬁc pollution
sources. Given the knowledge of the chemical characteristics of known sources,
83investigators infer pollution source contributions via a source apportionment or
multivariate receptor analysis (Nikolov et al., 2006). These approaches typically
begin by sampling pollution composition and inferring the likely pollution sources
by matching common chemical and physical characteristics between source and
air pollution samples. These methods have been shown to effectively quantify
the relative contribution of the different sources to ambient air pollution. In ag-
gregate, source apportionment begins by ambient sampling of the concentrations
of individual PM constituents. Second, investigators must conduct source proﬁl-
ing where each of the appropriate chemical constituents (receptors/markers) are
grouped according to emission source. Third, based on the source proﬁling one
can construct estimates of the contributions to ambient pollution levels from each
identiﬁed source. This approach is advantageous if the pollutants responsible for
the health effects are emitted from only one source. If the health effect is associ-
ated with a single element, grouping elements with varying toxicities into a single
source can attenuate the health effect (Suh et al., 2011).
The second approach is the use of a hierarchical regression model. Research has
shown that hierarchical models outperform conventional regression approaches
such as multiple linear regression with multiple exposures, when analyzing epi-
demiologic data on multiple exposures (Witte et al., 2000; Thomas et al., 2007). The
models attempt to measure the relationship between the health outcome and expo-
sure when the exposure variables have meaningful structures or groupings (Witte
et al., 1998; Young et al., 2008). For example, rather than estimating independent
effects of each pollution constituent separately, this approach seeks to estimate the
association between a health outcome and groups of elements that might be de-
ﬁned by chemical properties or other characteristics of the individual exposures.
At the ﬁrst stage, the model contains all of the elements/pollution constituents
84as covariates so there is no need for preliminary variable selection. The approach
then relates the independent effects of individual pollution constituents to charac-
teristics of these individual exposures in a second stage regression. Therefore the
hypotheses that risks differ by pollutant chemical property could be tested (Suh et
al., 2011).
The purpose of this paper is to compare the statistical performance of the two ap-
proaches by conducting a simulation study. Several existing studies have used one
of these approaches to analyze multi-pollutant health effects. (Lall et al., 2011; Ito
et al.; Laden et al, 2000). Alternatively, the hierarchical regression approach has
been used by Suh et al, 2011. None of these studies have sought to compare the
testingperformances ofthesemethods invarioustime seriessettings. For ouranal-
yses, each method will be constructed under varying initial settings established by
previous study estimates (Hopke et al., 2006). For the source apportionment, an
exploratory factor analysis was applied to the exposure data collected at Harvard
School of Public Health to get estimates of the source contributions (Nikolov et al.,
2006). For the hierarchical regression models, the choice of second stage covariates
were also pre-speciﬁed. The power calculations and type I errors will be reported
and analyzed. Lastly, each approach will be compared using simulated data to
determine the appropriateness of its use.
The remainder of this paper is as follows: Section 3.3 reviews the pollution study
data and the experimental design. Section 3.4 describes factor analysis for times se-
ries data and then presents the two-stage hierarchical modeling approach. Section
3.5 details the simulation study to examine the statistical properties of the health
effects estimates obtained from the two-stage and factor analysis approaches along
with the corresponding results. Section 3.6 discusses the ﬁndings and the potential
85implications of the research.
3.3 DATA AND STUDY DESIGN
Investigators often use time series methods and data to describe the relationship
between pollutants and health outcomes. In this study design the day-to-day vari-
ations in elemental concentrations are employed to identify the sources of pollu-
tion and are correlated with daily mortality or hospital admission counts. Time
series methods also allow for time varying confounders to be included in the anal-
yses through adjustments for temperature, humidity, year, season, and days of the
week. The daily sampling schedule provides greater power and allows the inves-
tigation of distributed lag effects that may not be possible in other analyses (Lall
et al., 2011). Some investigators have also been able to include pollution source
(source related PM2:5) information through factor analyses in their times series
models (Lall et al., 2011).
The data that motivates the proposed research are from environmental health time
series studies where PM2:5 composition data are collected on each day. The pri-
mary exposure of interest is daily source-related ﬁne particulate matter or aerody-
namic diameter  2.5 m (PM2:5) and its relation to mortality or hospital admis-
sions.
863.4 MODEL AND NOTATION
3.4.1 Factor Analysis Modeling Framework
We consider a full-likelihood approach that estimates the source contributions
from the receptor model and subsequently substitutes the estimates into the health
effects model taking the form of a generalized linear regression model. The factor
model is as follows:
Receptor Model:
Xt = St + 
X
t (3.1)
g(t) = 0 + 
TSt (3.2)
Notationally, Xt is the vector of [p  1] elemental concentrations for a given time
t(day).  is the [pk] matrix of factor loadings, St is a [k1] vector of unobserved
source contributions. Yt is the health outcome for a given time t. The  represent
[1  k] effect estimates for the k pollution sources. Each component (elemental
concentration) of Xt is represented by equation (3.1).
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p1 p2 ::: ::: pk
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[pk]
;
Xit =
k X
j=1
ijsjt + 
X
it (3.3)
For the ith element (1  i  p), the jth factor loading (1  j  k), for day t
(1  t  T). The distributional assumptions are as follows:
St  N(;)
X
t  N(0;	)
88where,
 =
2
6 6
6 6 6 6 6 6
6 6
4
2
1 0 0 ::: 0
0 2
2 0 0
0 0 2
3 ::: 0
. . .
. . .
. . . ... . . .
0 0 0 ::: 2
k
3
7 7 7
7 7 7 7 7
7 7
5
;	 =
2
6 6 6
6 6 6 6 6
6 6
4
 2
1 0 0 ::: 0
0  2
2 0 ::: 0
0 0  2
3 ::: 0
. . .
. . .
. . . ... . . .
0 0 0 :::  2
p
3
7 7 7 7
7 7 7 7 7
7
5
3.4.2 Two-Stage Hierarchical Regression Modeling Framework
The Greenland (1993) method of hierarchical modeling seeks to perform dimen-
sion reduction on the effect estimates associated with multiple exposures rather
than the exposures variables themselves. Given equation (3.4) from section 3.3, the
corresponding health effects estimates () are calculated. Since the exposure vari-
ables may be correlated or if there are not enough events to accurately estimate the
’s, these estimates are often unstable. A hierarchical approach can often remedy
some of these issues. The two-stage approach takes the form:
g(t) = 0 + 
TXt (3.4)
i = !
TZi + i;i 2 1;:::;p: (3.5)
By substituting equation (3.5) into equation (3.4) we have the following model:
g(t) =  + XtZ! + Xt; (3.6)
where the ! are treated as a vector of ﬁxed coefﬁcients while  is treated as a vec-
89tor of random coefﬁcients with mean 0 and variance 2. The ith row of Z contains
second-stage covariates for the ith exposure in i. ! is a vector of second-stage re-
gression coefﬁcients, and the elements of i are independent normal random vari-
ables with zero means and variances 2. Hence, as described above, we use the
second-stage covariates (that is, columns of Z) to model similarities among the i
in an attempt to improve conventional estimates from equation (3.4).
For cases when we are interested in assessing the health effects of PM sources, the
question arises of which second stage covariate matrix (Z) should be chosen. If
one were to ﬁt model (3.5) in two distinct stages, then the estimates for the second
stage coefﬁcients ! would take the following form:
b ! = (Z
TZ)
 1Z
T b :
This shows that the second stage effect estimates (b !) are a function of the Z ma-
trix and the health effects estimates () from the elemental concentrations. This
relationship provides a motivation for some connection between the source appor-
tionment and two stage approaches. In the next section, to further motivate our
choices for Z, we consider a special case of a source apportionment model with
Xit =
Pk
j=1 ijsjt + X
it, where we allow the second stage covariates (Z) to become
different variations of the factor loadings .
90Dimension Reduction
Factor analysis seeks dimension reduction of the receptor model by reducing the
dimension of the exposure in the health effects model. By substituting equation
(3.3) into equation (3.4) below, the model is reduced from p to k dimensions for
(k < p) different source contributions.
g(t) = 0 + 1X1t + 2X2t +  + pXpt
= 0 + 1
"
k X
j=1
1jsjt
#
+ 2
"
k X
j=1
2jsjt
#
+  + p
"
k X
j=1
pjtsjt
#
= 0 + 1 [11s1t +  + 1kskt] +  + p [p1s1t +  + pkskt]
= 0 + [111s1t +  + 11kskt] +  + [pp1s1t +  + ppkskt]
= 0 + [111s1t +  + pp1s1t] +  + [11kskt + 22kskt +  + ppkskt]
Therefore, the equations become:
g(t) = 0 +
1 z }| {
[111 + 221 +  + pp1]s1t +
2 z }| {
[112 + 222 +  + pp2]s2t + :::
+
k z }| {
[11k + 22k +  + ppk]skt
= 0 + 1s1t + 2s2t +  + kskt
91^ j =
p X
i=1
iij (3.7)
Which means that the health effects represented by the k PM sources (^ j) are a
linear combination of the element-speciﬁc coefﬁcients (i), weighted by the load-
ings of the elements for that speciﬁc source. Given these considerations, at least
thee choices of Z may be reasonable in the hierarchical formulation, each of which
allow Z to represent a variation of the factor loading matrix.
1. The non-overlapping case, where Zij = 1 if the source has the highest loading
for the particular element and Zij = 0 for the remaining sources for that
element.
2. A moderately overlapping case, where Zij = 1 if the source loading is greater
than some constant threshold and Zij = 0 for the remaining sources for that
element.
3. A general case, where Zij = zij where the zij could be representation of real
factor loadings measured or those given be previous or existing studies. Each
source has its own contribution for each element. In our case, we allow
zij = ij, where each ij is the factor loading for each element and source
combination from concentrator data.
Case 1 (No Overlap):
Assume the following sample Z:
92Z =
2
6 6 6
6 6 6 6 6 6
6 6 6 6 6
6 6 6 6 6 6
6 6 6 6
4
11 0 0 0
21 0 0 0
31 0 0 0
0 42 0 0
0 52 0 0
0 62 0 0
0 0 73 :::
. . .
. . .
. . . ...
0 0 ::: pk
3
7 7 7
7 7 7 7 7 7
7 7 7 7 7 7
7 7 7 7 7
7 7 7 7
5
[pk]
; (3.8)
where Z represents the p elemental concentrations for the kth source contribution
and b  is a p  1 vector of coefﬁcient estimates given from the health effects model
in equation (3.4). In this simple form of the factor loadings given by equation
(3.8), we choose Z to contain indicators reﬂecting which source is most responsible
for an element. In essence the Zij = f1;0g and each elemental concentration is
assumed to be given fully by one source contribution. Each ij does not have to be
exactly like (3.8) the only restriction is that there is one non-zero factor loading per
row. Therefore, the normal equations and corresponding health effects estimates
are given by the following k  1 matrix :
b ! = (Z
TZ)
 1Z
T b  =
2
6 6 6
6 6 6 6
4
Pp
i=1 i1 ^ i Pp
i=1 i1
Pp
i=1 i2 ^ i Pp
i=1 i2
. . .
Pp
i=1 ik ^ i Pp
i=1 ik
3
7 7
7 7 7 7 7
5
[k1]
: (3.9)
93In this simple case b !j =
Pp
i=1 ij ^ i Pp
i=1 ij whereas b j =
Pp
i=1 ij ^ i. In this case there are
overlapping terms and b !j proportional to b j. An example of the simple case of Z
could be the following where p = 13, k = 4:
Znon overlapexample =
2
6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6
4
1 0 0 0
1 0 0 0
1 0 0 0
0 1 0 0
0 1 0 0
0 1 0 0
0 0 1 0
0 0 1 0
0 0 1 0
0 0 0 1
0 0 0 1
0 0 0 1
0 0 0 1
3
7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7
5
[pk]
Given this particular scenario and using the general equations for b  and b ! the health
effects estimates can be calculated as seen in Table 3.1.
Estimates b  b !
1 ^ 1 + ^ 2 + ^ 3
^ 1+ ^ 2 + ^ 3
3
2 ^ 4 + ^ 5 + ^ 6
^ 4+ ^ 5 + ^ 6
3
3 ^ 7 + ^ 8 + ^ 9
^ 7+ ^ 8 + ^ 9
3
4 ^ 10 + ^ 11 + ^ 12 + ^ 13
^ 10+^ 11+^ 12+^ 13
4
Table 3.1: Health effects estimates for b  and b !
94Case 2 (Moderately Overlapping Case):
In general, an element is not generated from a single source, which is why the source
proﬁles of a typical () are not non-zero for only one entry per row as in case 1. In these
settings where a single element is spread across many sources, we can extend the choice of
Z from case 1 to include such settings. We propose 2 new variations: In the ﬁrst variation
we use indicators wherever the source proﬁles are greater than some threshold C and will
be called the ”moderately overlapping case”. In this case, an element’s loadings can be
distributed across different sources but indicator values (0,1) are still used. Assume  has
the following form:
1 =
2
6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6
4
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
0:88 0:00 0:01 0:00
0:83 0:08 0:34 0:09
0:91 0:02 0:31 0:17
0:00 0:95 0:00 0:01
0:02 0:65 0:05 0:26
0:16 0:04 1:02 0:03
0:18 0:58 0:26 0:43
0:17 0:41 0:44 0:65
0:13 0:27 0:51 0:81
3
7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7
5
[pk]
(3.10)
Given these values of 1, an appropriate ”moderately overlapping” Z matrix can be con-
structed. By allowing each value of ij  :30 to be valued at 1 and ij < :30 to be valued
95at 0 we are left with the following Z matrix.
Zmod:overlap =
2
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
6 6
4
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
1 0 0 0
1 0 1 0
1 0 1 0
0 1 0 0
0 1 0 0
0 0 1 0
0 1 0 1
0 1 1 1
0 0 1 1
3
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
7 7
5
[pk]
Case 3 (General Overlapping Case):
In the third and last variation of the second stage covariates we choose Z to be exactly
equal to the true 1 given in equation (3.10). In this case, each of the elemental concentra-
tions can be attributed to more than one source and the values represent real-valued factor
loadings that are not restricted to indicators. With this assumption, the normal equations
for both case 2 and case 3 can be generalized to:
96b ! = (ZTZ) 1ZT b  =
2
6
6 6
6 6
6 6
4
c111 + c122 + c133 + c144 +  + c1kk
c211 + c222 + c233 + c244 +  + c2kk
. . .
ck11 + ck22 + ck33 + ck44 +  + ckkk
3
7
7 7
7 7
7 7
5
[k1]
Therefore, in the overlapping case b !j =
Pk
i=1 cji()b () whereas b j =
Pp
i=1 iij. The
two estimates differ by a factor of cji so there are some overlapping terms in the estimates.
The cji represent the components of the (ZTZ) 1 matrix and are functions of the ij. Again
thei arelinearcombinationsofthehealtheffectsestimatesandthespeciﬁcfactorloadings
given by ij .
3.5 SIMULATION STDY
We conducted a simulation study to examine the statistical properties of the health effects
estimates obtained from the two-stage and factor analysis approaches. The objective of
this simulation is to compare the two methods and determine the settings where each
scheme is most powerful in detecting differences and maintaining low type 1 errors. The
standard errors from the two models are also reported so that comparisons in efﬁciency
can be made.
3.5.1 Simulating Source Data
We assume k = 4 source contributions. Although the source contributions are not directly
observed or measured in the studies motivating this research, we simulate them in this
study so that they are effectively known. First we simulate the source contributions St
97according to the following normal distribution:
St  MV N4(;);
where  = 0. Given each set of source contributions we are then able to simulate the
corresponding elemental concentrations from
XtjSt  MV N13(St;	)
diag() =
2
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6 6
6 6
6 6
4
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7 7
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diag(	) =
2
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;	13 =
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98Both 	 and  represent realistic variance structures for the source contribu-
tions and the exposure data respectively given by settings from concentrator data
(Nikolov et al., 2000). We assume the factor loadings of  follow the given form.
Because the source proﬁles are unknown and the source contributions are unob-
served the model may not be indentiﬁable and will not have a unique solution.
The model can be made indentiﬁable by constraining some of the factor loadings
in 1. The elements silicon (Si), sulfur (S), Nickel (Ni), and organic carbon (OC)
were chosen to be constrained because they were most unilaterally emitted by sin-
gle sources.
1 =
2
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6 6
6 6
6 6
6 6
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S1 S2 S3 S4
Si 1 0 0 0
S 0 1 0 0
Ni 0 0 1 0
OC 0 0 0 1
Al 0:88 0:00 0:01 0:00
Ti 0:83 0:08 0:34 0:09
Ca 0:91 0:02 0:31 0:17
Sulf 0:00 0:95 0:00 0:01
Se 0:02 0:65 0:05 0:26
V 0:16 0:04 1:02 0:03
Br 0:18 0:58 0:26 0:43
BC 0:17 0:41 0:44 0:65
EC 0:13 0:27 0:51 0:81
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993.5.2 Simulating Health Outcome Data
The health outcome was simulated using a poisson distribution, since data repre-
sented counts. The outcomes of interest were mortality and number of hospital
admissions. Further, we generated health outcome assuming a health effect from
a single source
Yt  Pois();
where k is the source contribution at time t. Therefore,
Y
(1)
t jf1 = 1;2 = 3 = 4 = 0g  Pois( = exp(0 + 1S1);
Y
(2)
t jf2 = 2;1 = 3 = 4 = 0g  Pois( = exp(0 + 2S2);
Y
(3)
t jf3 = 3;1 = 2 = 4 = 0g  Pois( = exp(0 + 3S3);
Y
(4)
t jf4 = 4;1 = 2 = 3 = 0g  Pois( = exp(0 + 4S4):
Where Y
(1)
t j1 represents the outcome associated with only the ﬁrst source.
Y
(2)
t j2, Y
(3)
t j3, and Y
(4)
t j4 are interpreted in the corresponding way. In the simu-
lation we generate the health effect on each of the four sources individually. There-
fore we have four sets of health outcomes Y
(1)
t , Y
(2)
t , Y
(3)
t , Y
(4)
t , where each health
effect corresponds to a different pollution source. The initial health outcome pa-
rameters were given by the following values:0 = 3:00,
1001 = f0;0:05;0:10;0:15;0:20;0:25;0:30;0:35;0:40g
2 = f0;0:05;0:10;0:15;0:20;0:25;0:30;0:35;0:40g
3 = f0;0:05;0:10;0:15;0:20;0:25;0:30;0:35;0:40g
4 = f0;0:05;0:10;0:15;0:20;0:25;0:30;0:35;0:40g
Each model was run for T = 3000 days, N = 13 elemental concentrations, and
k = 4 pollution sources. Each simulation was run for 1000 iterations.
3.5.3 Approaches
1. Known source contribution model: We previously noted that the sources
were simulated so we estimate the health effects based on the known source
contributions using the poisson model.
Xt = St + 
X
t
log(t) = 0 + 
TSt
2. Factor Analyses: We conducted a conﬁrmatory factor analyses (CFA) using
the SEM package in R in order to get estimates for the corresponding fac-
tor scores (estimated source contributions). The aforementioned initial val-
ues and the constrained factor loadings were used. Next, we performed an
exploratory factor analysis (EFA) using the ”factanal” package in R and a
101principle components analysis (PCA) using the ”princomp” package in R.
Both the EFA and the PCA models do not assume the factor loading struc-
ture nor do they assume a distribution for the source contributions. Once the
estimates for the respective source contributions were determined, a poisson
model was subsequently ﬁt.
Xt = St + 
X
t
log(t) = 0 + 
T^ St
3. Two-Stage Approach: We begin with the health effects model. In the sec-
ond stage, we choose covariates Z to model similarities among the i in an
attempt to improve conventional estimates from the health effects model.
log(t) = 0 + 
TXt
i;[131] = Z[134]![41] + i;[131];i 2 1;:::;p
therefore,
log(t) = 0 + XtZ! + Xt
3.5.4 Choice of Second Stage Covariates
We allowed for three cases in the choice for Z.
 An non overlapping case we assume a simple form for the factor loadings
102of Z. Each elemental concentration is assumed to be attributed fully to one
source contribution. This is done by taking the largest source contribution
value for a given elemental concentration.
 A moderately overlapping case where we allowed each value of  : ij  0.3
to be valued at 1 and  : ij < 0.3 to be valued at 0. For some C > 0.
 In the overlapping case we assume each of the elemental concentrations can
be attributed to more than one source. In this case we allow Z to be our initial
case  (Z = ).
The three Z matrices follow:
Zno overlap =
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;Zgeneralcase =
2
6 6
6
6 6
6 6
6
6 6
6
6 6
6
6 6
6
6 6
6 6
6
6 6
6
6 6
6
6 6
6
6 6
6 6
6
6
4
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
0:88 0:00 0:01 0:00
0:83 0:08 0:34 0:09
0:91 0:02 0:31 0:17
0:00 0:95 0:00 0:01
0:02 0:65 0:05 0:26
0:16 0:04 1:02 0:03
0:18 0:58 0:26 0:43
0:17 0:41 0:44 0:65
0:13 0:27 0:51 0:81
3
7 7
7
7 7
7 7
7
7 7
7
7 7
7
7 7
7
7 7
7 7
7
7 7
7
7 7
7
7 7
7
7 7
7 7
7
7
5
103..
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Power:α ^
1
α1
P
o
w
e
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
2
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
3
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
4
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
Figure 3.1: Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	given : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 1. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 1. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 1.
3.5.5 Simulation Results
Figures 3.1 and 3.2 display power and type 1 error curves for the health effects
estimates obtained from ﬁve different modeling schemes. The health effects es-
timates given by the known source contribution model (KSC) are considered the
”gold standard”. The health effects estimates from the estimated source contribu-
tions was determined using three different computing packages. The ”CFA” for
the conﬁrmatory factor ananlysis using structural equation modeling package in
R, ”EFA” for the exploratory factor analysis (factanal package in R), and ”PCA” for
the principle components analysis (princomp package in R). There were three ver-
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Figure 3.2: Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2. B(top right): The
power for ^ 2 of each health effects model at a given initial value of 2. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 2. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 2.
sions of the two-stage regression approach taken; 1) The second-stage covariates
did not overlap (”TSnov”) and 2) where the second stage covariates do overlap
(”TSmod”), and lastly the where the second stage covariates equal  (”TSlam”).
Each two-stage regression model of was run in glmmPQL package in R.
Each ﬁgure consists of four graphs that represent calculations for the health effects
estimates ^ 1, ^ 2, ^ 3, and ^ 4 at different initial values given along the x-axis. Each
model was simulated so that one speciﬁc source would be responsible for the en-
tire health effect. For example, Figure 3.1 represents Y
(1)
t jSt which denotes that the
health effect was simulated to be associated with source 1. Simultaneously, sources
1052 through 4 were assumed to have no association with the outcome. Therefore, Fig-
ure 3.1A (top left) shows six power curves at varying initial values that represent
each of the afore mentioned methods. The expectation is that the power curves to
detect differences in position A would be quite high because that is where the true
association lies. Alternatively, positions 3.1B (top right), 3.1C (bottom left), and
3.1D (bottom right) show seven type 1 error curves each at the varying initial val-
ues of 1. The expectation is that the type 1 errors in positions 3.1B through 3.1D
would be quite low (Prfdetect a difference j there is no differenceg = 0.05) because
these sources were assumed to have no effect.
Figure 3.1A shows the power curves for ^ 1 (outcome Y
(1)
t given the health effect
is only associated with source 1. The 4 source apportionment power curves (CFA,
EFA, PCA, and KSC) begin at approximately 0.05 when 1 = 0 but increase to
nearly 100% for increasing initial values of the health effect estimate (1). This
means that the source apportionment approach is able to estimate the appropriate
effect with high power. Similarly, the 3 two-stage regression power curves (TSnov,
TSov, and TSlam) follow that same pattern and increase in power for larger values
of 1. Figure 3.1B shows type 1 error curves for ^ 2 (Y
(1)
t given that the source 2 re-
ﬂects a zero contribution to the health effect). The CFA, EFA, and PCA approaches
show increasing ^ 2 type 1 errors for increasing initial values of 1. As the initial
health effect estimate (1) increases the proportion of false positives for ^ 2 rises
from approximately 0.05 to 0.30. Alternatively, the type 1 errors for ^ 2 from ap-
proaches TSnov, TSmod, TSlam, and KSC straddle the 0.05 line for all values of
1. Figure 3.1C shows type 1 error curves for ^ 3 which reﬂects the outcome (Y
(1)
t )
given that source 3 reﬂects a zero contribution to the health effect. For the health
effect ^ 3, the CFA, EFA, and PCA approaches again show increasing type 1 errors
with increasing initial values of 1. As the health effect estimate 1 increases the
106proportion of false positives for ^ 3 rises from approximately 0.05 to 0.90. TSmod
maintains a high type 1 error rate throughout the varying initial values of 1. On
the other hand, the TSnov and TSlam models have high type 1 error rates in the
early values of 1 but returns to below 0.05 when 1 = 0:15. The KSC model type 1
error curve straddles the 0.05 line as expected because the true simulated sources
were used. Figure 3.1D shows type 1 error curves for ^ 4 where the outcome (Y
(1)
t )
is given that the source 4 reﬂects a zero contribution to the health effect. The type
1 error for ^ 4 from the CFA, EFA, and PCA approaches show increasing type 1
errors with increasing initial values of 1. As the initial health effect estimate (1)
increases the proportion of false positives from ^ 4 rise from approximately 0.05 to
0.55. The type 1 errors for ^ 4 in the TSnov, TSmod, and TSlam approaches experi-
ence slight increases int type 1 errors for initial values before 1 = 0:20. For initial
values after 1 = 0:20, the type 1 error rates for ^ 4 in models TSnov, TSmod, and
TSlam decrease to below 0.05.
Overall, the simulation suggests different patterns for the factor analyses and the
two stage approaches. For the factor analyses, the sources with the clear simulated
relationship are able to produce effect estimates that are highly powered. For the
remaining sources with no association to the health outcome, there are inﬂated
type 1 errors. The source apportionment methods in particular show increasing
type 1 errors for increasing initial health effect estimate values, for all settings ir-
respective of source variance structures. This would indicate that when there is
a large signal (health effect estimate) from one source, there is an accompanying
spill-over effect into the other sources. Both the EFA and PCA models have the
highest type 1 error levels while the CFA has just moderate increases.
On the other hand the two stage approaches showed different patterns. For both
107the non-overlapping, moderately overlapping, and the general two stage cases,
the power to detect differences is very high for the source with the clear simulated
effect. Alternatively, the sources that have no association to the health outcome
experience high type 1 error spikes which is in contrast with the factor analysis
models. For smaller health effect estimate values between  = 0:0   0:20, there
are large increases in the type 1 error rates. This would indicate that the two-stage
approach has difﬁculties estimating health effects that are very small but once the
health effects become larger in magnitude the type 1 error rates come down to
normal levels. Another possible predictor of the spikes in type 1 error rates for
the two-stage approaches are the distribution of single elements across the many
sources. There is a tendency for the spikes to coincide with health effects where
the elements are evenly spread across different sources.
3.5.6 Simulation Implications
The conﬁrmatory factor analysis procedures (CFA) are able to estimate the source
contributions and health effects estimates with relatively low bias as can be seen
in Table 3.2. Table 3.2 shows the health effects estimates from a conﬁrmatory fac-
tor analysis along with the model standard errors and the simulation standard
deviations. There are 4 sets of initial values represented in Table 3.2: 1) top left:
fY
(1)
t j1 = 0:05;2 = 0;3 = 0;4 = 0gwhich means the health effect associ-
ated with source 1 is 0.05 while the effect of the other sources is 0, 2) bottom
left: fY
(2)
t j = 0;2 = 0:05;3 = 0;4 = 0gwhich means the health effect asso-
ciated with source 2 is 0.05 while the effect of the other sources is 0, 3) top right:
fY
(1)
t j1 = 0:30;2 = 0;3 = 0;4 = 0g, and 4) fY
(2)
t j1 = 0;2 = 0:30;3 = 0;4 =
0g. Since the health effects estimates are unbiased, then the variability of the es-
108timates maybe leading to the higher false positive rates due to the bias-variance
trade off. Similar evidence of the discrepancy between the model standard errors
and the simulation standard deviations can be seen in Tables 3.2 - 3.4. Each of the
standard deviation estimates are larger than the standard error estimates for EFA
andPCAmodelswhilethispatternispresentbutattenuatedintheCFAmodel. For
example in Table 3.2A, the CFA health effect estimate ^ 1 is 0.05001 which is quite
close to the simulated value of 0.05, the standard error is 0.0027 and the standard
deviation is 0.0026. On the other hand, in Tables 3.3 and 3.4 show that the standard
deviations are in most cases twice as large as the standard errors for large values
of . For example, in Table 3.3C it is noted that the SE for ^ 1 is 0.0039 while the SD
is 0.0070 for initial values of 0.30. In order to correct the discrepancy in errors, a
bootstrap model can be conducted which will give more accurate estimates of the
precision/variability. Subsequently, the number of false positives will be reduced
to below 0.05 and the power estimates will be regulated/attenuated.
YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. CFA Est. Std Err. Std. Dev.
^ 1 0.0500 0.0027 0.0026
^ 2 -0.0002 0.0033 0.0033
^ 3 0.0001 0.0034 0.0034
^ 4 0.0000 0.0033 0.0032
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. CFA Est. Std Err. Std. Dev.
^ 1 0.0000 0.0027 0.0028
^ 2 0.0500 0.0033 0.0033
^ 3 0.0002 0.0034 0.0034
^ 4 0.0000 0.0033 0.0034
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. CFA Est. Std Err. Std. Dev.
^ 1 0.2999 0.0025 0.0027
^ 2 0.0001 0.0031 0.0032
^ 3 -0.0004 0.0032 0.0035
^ 4 0.0002 0.0031 0.0033
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. CFA Est. Std Err. Std. Dev.
^ 1 0.0000 0.0026 0.0026
^ 2 0.3001 0.0031 0.0033
^ 3 -0.0003 0.0033 0.0033
^ 4 -0.0001 0.0032 0.0034
Table 3.2: A(top left), B(bottom left), C(top right), D(bottom right): This table represents the
parameter estimates and errors for the conﬁrmatory factor analyses (CFA) models conducted on
simulated data. Generalized linear models were conducted for 1000 iterations. The subsequent
estimates were aggregated into medians. Each model included no covariates.
Alternatively, the two-stage hierarchical regression approach is unable to estimate
the health effects estimates without bias. The actual health effects estimates are
cannot be compared to the source apportionment models because they represent
109different values. Each two-stage model represents the relationship between ﬁrst
and second stage covariates and the health outcome. In addition, the estimates are
poorly estimated due to the correlations between sources. Such correlations occur
when a single element is distributed among many sources. Table 3.5 shows the
health effects estimates and errors from the two-stage model. For this approach,
therearediscrepanciesbetweenthemodelstandarderrorsandthesimulationstan-
dard deviations when there are spikes in the type 1 error curves. and the standard
errors are very similar and in some cases smaller than those of the standard devia-
tions. Therefore, this does not seem to represent a variance issue and the bootstrap
will be ineffective.
YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. EFA Std Err. EFA Std Dev.
^ 1 0.0041 0.0044
^ 2 0.0041 0.0041
^ 3 0.0042 0.0043
^ 4 0.0041 0.0041
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. EFA Std Err. EFA Std Dev.
^ 1 0.0041 0.0041
^ 2 0.0041 0.0041
^ 3 0.0042 0.0043
^ 4 0.0041 0.0039
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. EFA Std Err EFA Std Dev.
^ 1 0.0039 0.0070
^ 2 0.0039 0.0056
^ 3 0.0040 0.0056
^ 4 0.0039 0.0052
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. EFA Std Err. EFA Std Dev.
^ 1 0.0040 0.0056
^ 2 0.0040 0.0063
^ 3 0.0040 0.0052
^ 4 0.0040 0.0052
Table 3.3: A(top left), B(bottom left), C(top right), D(bottom right): This table represents the
parameter estimates and errors for the conﬁrmatory factor analyses (EFA) models conducted on
simulated data. Generalized linear models were conducted for 1000 iterations. The subsequent
estimates were aggregated into medians, and 95% CI’s. Each model included no covariates.
Bootstrap Option/Solution
The bootstrap procedure for the CFA was chosen so that the precision of the health
effects estimate (regression coefﬁcient) could be evaluated. For each data set, b =
100 bootstrap samples 1;:::;100 was retrieved. T = 3000 days, N = 13 elemental
concentrations, K = 4 sources, and r = 100 iterations. First, the CFA model was
ﬁt using the observed/simulated data and the following estimates were reported:
110YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. PCA Std Err. PCA Std Dev.
^ 1 0.0041 0.0043
^ 2 0.0041 0.0040
^ 3 0.0041 0.0042
^ 4 0.0041 0.0041
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. PCA Std Err. PCA Std Dev.
^ 1 0.0041 0.0041
^ 2 0.0041 0.0041
^ 3 0.0041 0.0042
^ 4 0.0041 0.003
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. PCA Std Err PCA Std Dev.
^ 1 0.0039 0.0071
^ 2 0.0039 0.0056
^ 3 0.0039 0.0054
^ 4 0.0039 0.0056
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. PCA Std Err. PCA Std Dev.
^ 1 0.0039 0.0057
^ 2 0.0039 0.0063
^ 3 0.0039 0.0050
^ 4 0.0039 0.0053
Table 3.4: A(top left), B(bottom left), C(top right), D(bottom right):This table represents the pa-
rameter estimates and errors for the conﬁrmatory factor analyses (PCA) models conducted on sim-
ulated data. Generalized linear models were conducted for 1000 iterations. The subsequent esti-
mates were aggregated into medians, and 95% CI’s. Each model included no covariates.
YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. TSnov Est. Std Err. Std Dev.
^ 1 0.0137 0.0007 0.0007
^ 2 -0.0001 0.0011 0.0011
^ 3 -0.0036 0.0017 0.0017
^ 4 -0.0012 0.0014 0.0014
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. TSnov Est. Std Err. Std Dev.
^ 1 -0.0005 0.0007 0.0007
^ 2 0.0156 0.0011 0.0012
^ 3 -0.0003 0.0018 0.0017
^ 4 -0.0038 0.0014 0.0016
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. TSnov Est. Std Err. Std Dev.
^ 1 0.0807 0.0163 0.0009
^ 2 -0.0001 0.0163 0.0016
^ 3 -0.0078 0.0232 0.0027
^ 4 -0.0025 0.0189 0.0021
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. TSnov Est. Std Err. Std Dev.
^ 1 -0.0007 0.0188 0.0010
^ 2 0.0780 0.0189 0.0017
^ 3 -0.0015 0.0267 0.0026
^ 4 -0.0026 0.0218 0.0022
Table 3.5: A(top left), B(bottom left), C(top right), D(bottom right):This table represents the pa-
rameter estimates and errors for the two-stage hierarchical regression models conducted on simu-
lateddata. Generalizedlinearmodelswereconductedfor1000iterations. Thesubsequentestimates
were aggregated into medians. Each model included no covariates.
^ , ^ 	,^ , and ^ . Second, using these initial values, bootstrapped source data was
generated from S(b)  N(0; ^ ). Third, bootstrapped exposure (elemental concen-
trations) data were generated from X
(b)
t  N(^ S(b); ^ ). Lastly, health outcome
data were generated from Y(b)  Pois((b)), where (b) = exp(^ S(b)). As a result
of this simulation structure poisson linear models could be ﬁt using Y(b) and X(b)
as real data. From each of the 100 bootstrap samples the ^ (b) regression coefﬁcients
for each source were stored and the 2.5% and 97.5% bootstrap conﬁdence intervals
were calculated. The simulation was run for r =100 iterations which yielded 100
111conﬁdence intervals for each source. Subsequently, the power and type 1 errors
were calculated.
The bootstrap procedure for the two-stage model begins with b = 100 bootstrap
samples 1;:::;100 for each data set. T = 3000 days, N = 13 elemental concentra-
tions, K = 4 sources, and r = 200 iterations. The two-stage model was ﬁt using
observed/simulated data and ^ ! for each source, ^ 2
, and ^ . Given the original sim-
ulated exposure data (elemental concentrations) Xt and the second stage covariate
matrix Z the bootstrap mean outcome can be estimated. The mean is given by
(b) = exp(^ 0 + XtZ^ ! + Xt^ g. Lastly, the health outcome data is generated from
Y(b)  Poisson((b)). The two stage model is reﬁt and the from each of the 100
bootstrap samples and the ^ !(b)) regression coefﬁcients for each source were stored.
The 2.5% and 97.5% bootstrap conﬁdence intervals were calculated. The simula-
tion was run for r =200 iterations which yielded 200 conﬁdence intervals for each
source. Subsequently, the power and type 1 errors were calculated.
Bootstrap Results
Figure 3.3 shows the CFA bootstrap power and type 1 error curves. Figure 3.3A
shows the power curves for outcome Yt given the health effect is only associated
with source 1 (St). The power ranges from 0.65 to 0.85. Figures 3.3B, 3.3C, and 3.3D
show the type 1 error curves and they all are below 0.05 which is expected. Figure
4 shows the power curves for outcome Yt given the health effect is only associated
with source 2(S2) and the patterns are the same.
Figures 3.5 and 3.6 show the two-stage bootstrap power and type 1 error curves.
Figure 3.5A shows the power curves for outcome Y1t given the health effect is only
associated with source 1 (S1t). The power estimates are near 100% for all coefﬁcient
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Figure 3.3: CFA Bootstrap Power and Type 1 Error Curves for Y1tjS1t and 	given : A(top left):
The power for each health effects model at the given initial value of 11. B(top right): The type 1
error for each of the health effects models at a given initial value of 12. C(bottom left): The type 1
error for each of the health effects models at a given initial value of 13. D(bottom right): The type
1 error for each of the health effects models at a given initial value of 14.
values which is the same as the non-bootstrapped values. Figures 3.5B, 3.5C, and
3.5D show the type 1 error curves and they all similar to the non-bootstrapped
values which is expected. Figure 3.6 shows the power curves for outcome Y2t given
the health effect is only associated with source 2(S2t) and the patterns are the same.
3.6 DISCUSSION
In this paper we evaluated the factor analysis and two-stage hierarchical model
estimation procedures. Each model included all relevant exposures. Issues arise
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Figure 3.4: CFA Overlaid Power and Type 1 Error Curves for Y2tjS2t and 	given : A(top left):
The type 1 error for each of the health effects models at a given initial value of 21. B(top right):
The power for each health effects model at the given initial value of 22. C(bottom left): The type 1
error for each of the health effects models at a given initial value of 23. D(bottom right): The type
1 error for each of the health effects models at a given initial value of 24.
when estimating the effects of sources with no assumed effect on the outcome.
The expectation is that the type 1 error rates are to be  0:05. For each of the factor
analyses approaches the type I error rate was inﬂated for increasing values of the
corresponding effect estimate but the differences are larger in the EFA and PCA
models. This means that this source apportionment approach falsely rejects the
null hypothesis more than the allotted  = 0:05 for the sources that have no effect.
These patterns are echoed when the variance structures of the source contributions
are varied. Conducting a bootstrapped CFA model maintains the variability of the
effect estimates and the type 1 error rates so there is no effect. The EFA and PCA
bootstrapped models have similar results.
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Figure 3.5: CFA Bootstrap Power and Type 1 Error Curves for Y1tjS1t and 	given : A(top left):
The power for each health effects model at the given initial value of 11. B(top right): The type 1
error for each of the health effects models at a given initial value of 12. C(bottom left): The type 1
error for each of the health effects models at a given initial value of 13. D(bottom right): The type
1 error for each of the health effects models at a given initial value of 14.
The two-stage hierarchical model also has issues when estimating effects from
sources with no assumed association with the outcome. Much of the data from
these models have instances where there are spikes in the type I error rates for
low effect estimate values and then the rates go back to  0:05. The spikes oc-
cur when there are elements that occur predominantly in more than one source
(overlap). The simulation study seemed to suggest that the two-stage approach
where one element was associated with a particular source (no-overlap) yielded
the best results. When the variance structures of the source contributions were
changed, the type I error results from the two-stage models increased and were
greater than 0.05. Conducting the two-stage bootstrapped model is ineffective be-
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Figure 3.6: CFA Overlaid Power and Type 1 Error Curves for Y2tjS2t and 	given : A(top left):
The type 1 error for each of the health effects models at a given initial value of 21. B(top right):
The power for each health effects model at the given initial value of 22. C(bottom left): The type 1
error for each of the health effects models at a given initial value of 23. D(bottom right): The type
1 error for each of the health effects models at a given initial value of 24.
cause the variability of the effect estimates did not need to be adjusted rather the
estimates themselves were inaccurate.
These ﬁndings would indicate that both of these modeling approaches have the
ability to account for multiple exposures, estimate independent effects from cor-
related exposures, but each of the strategies has difﬁculty in accurately estimating
the unobserved source contributions which consequently lead to health effects es-
timates with high false positive probabilities. More work is needed to ensure that
proper control of false positives in empirical data settings.
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Figure 3.7: Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	given : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 1. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 1. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 1.
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Figure 3.8: Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 2. B(top right): The
power for ^ 2 of each health effects model at a given initial value of 2. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 2. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 2.
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Figure 3.9: Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 3. B(top right): The
type 1 error for ^ 2 of each health effects model at a given initial value of 3. C(bottom left): The
power for ^ 3 of each health effects model at a given initial value of 3. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 3.
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Figure 3.10: Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	given : A(top left): The
type 1 error for ^ 1 of each health effects model at the given initial value of 4. B(top right): The
type 1 error for ^ 2 of each health effects model at a given initial value of 4. C(bottom left): The
type 1 error for ^ 3 of each health effects model at a given initial value of 4. D(bottom right): The
power for ^ 4 of each health effects model at a given initial value of 4.
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Figure 3.11: Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	13 : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 1. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 1. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 1.
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Figure 3.12: Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	13 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 2. B(top right): The power
for ^ 2 of each health effects model at a given initial value of 2. C(bottom left): The type 1 error for
^ 3 of each health effects model at a given initial value of 2. D(bottom right): The type 1 error for
^ 4 of each health effects model at a given initial value of 2.
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Figure 3.13: Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	13 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 3. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 3. C(bottom left): The power for
^ 3 of each health effects model at a given initial value of 3. D(bottom right): The type 1 error for
^ 4 of each health effects model at a given initial value of 3.
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Figure 3.14: Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	13 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 4. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 4. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 4. D(bottom right): The power
for ^ 4 of each health effects model at a given initial value of 4.
124..
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Power:α ^
1
α1
P
o
w
e
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
2
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
3
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
0.00 0.10 0.20 0.30 0.40
0
.
0
0
0
.
2
5
0
.
5
0
0
.
7
5
1
.
0
0
Type 1 Error:α ^
4
α1
T
y
p
e
 
1
 
E
r
r
o
r
CFA
EFA
PCA
KSC
TSmod
TSnov
TSlam
Figure 3.15: Overlaid Power and Type 1 Error Curves for Y
(1)
t jSt and 	31 : A(top left): The
power for ^ 1 of each health effects model at the given initial value of 1. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 1. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 1. D(bottom right): The type 1
error for ^ 4 of each health effects model at a given initial value of 1.
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Figure 3.16: Overlaid Power and Type 1 Error Curves for Y
(2)
t jSt and 	31 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 2. B(top right): The power
for ^ 2 of each health effects model at a given initial value of 2. C(bottom left): The type 1 error for
^ 3 of each health effects model at a given initial value of 2. D(bottom right): The type 1 error for
^ 4 of each health effects model at a given initial value of 2.
YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. TSov Std Err. TSov Std Dev.
^ 1 0.0040 0.0030
^ 2 0.0049 0.0035
^ 3 0.0058 0.0045
^ 4 0.0085 0.0069
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. TSov Std Err. TSov Std Dev.
^ 1 0.0052 0.0028
^ 2 0.0062 0.0038
^ 3 0.0071 0.0046
^ 4 0.0101 0.0068
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. TSov Std Err TSov Std Dev.
^ 1 0.01906 0.0039
^ 2 0.0222 0.0050
^ 3 0.0245 0.0050
^ 4 0.0336 0.0073
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. TSov Std Err. TSov Std Dev.
^ 1 0.0228 0.0039
^ 2 0.0266 0.0049
^ 3 0.0293 0.0050
^ 4 0.0402 0.0071
Table 3.6: This table represents the parameter estimates and errors for the 2-stage ”overlap” mod-
els conducted on simulated data. Generalized linear models were conducted for 1000 iterations.
The subsequent estimates were aggregated into medians, and 95% CI’s. Each model included no
covariates.
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Figure 3.17: Overlaid Power and Type 1 Error Curves for Y
(3)
t jSt and 	31 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 3. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 3. C(bottom left): The power for
^ 3 of each health effects model at a given initial value of 3. D(bottom right): The type 1 error for
^ 4 of each health effects model at a given initial value of 3.
YtjSt, 1 = 0:05, 2 = 0, 3 = 0,4 = 0
Coef. TSnov Std Err. TSnov Std Dev.
^ 1 0.0008 0.0007
^ 2 0.0011 0.0011
^ 3 0.0017 0.0017
^ 4 0.0014 0.0014
YtjSt, 1 = 0:0, 2 = 0:05, 3 = 0,4 = 0
Coef. TSnov Std Err. TSnov Std Dev.
^ 1 0.0007 0.0008
^ 2 0.0011 0.0012
^ 3 0.0018 0.0017
^ 4 0.0014 0.0016
YtjSt, 1 = 0:30, 2 = 0, 3 = 0,4 = 0
Coef. TSnov Std Err TSnov Std Dev.
^ 1 0.0163 0.0009
^ 2 0.0163 0.0016
^ 3 0.0232 0.0027
^ 4 0.0189 0.0021
YtjSt, 1 = 0:0, 2 = 0:30, 3 = 0,4 = 0
Coef. TSnov Std Err. TSnov Std Dev.
^ 1 0.0188 0.0010
^ 2 0.0189 0.0017
^ 3 0.0267 0.0026
^ 4 0.0218 0.0022
Table 3.7: This table represents the parameter estimates and errors for the 2-stage ”no-overlap”
models conducted on simulated data. Generalized linear models were conducted for 1000 itera-
tions. The subsequent estimates were aggregated into medians, and 95% CI’s. Each model included
no covariates.
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Figure 3.18: Overlaid Power and Type 1 Error Curves for Y
(4)
t jSt and 	31 : A(top left): The type
1 error for ^ 1 of each health effects model at the given initial value of 4. B(top right): The type 1
error for ^ 2 of each health effects model at a given initial value of 4. C(bottom left): The type 1
error for ^ 3 of each health effects model at a given initial value of 4. D(bottom right): The power
for ^ 4 of each health effects model at a given initial value of 4.
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